<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="pmc-domain-id">1692</journal-id><journal-id journal-id-type="pmc-domain">nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430580</article-id><article-id pub-id-type="pmcid-ver">PMC12430580.1</article-id><article-id pub-id-type="pmcaid">12430580</article-id><article-id pub-id-type="pmcaiid">12430580</article-id><article-id pub-id-type="doi">10.3390/nu17172743</article-id><article-id pub-id-type="publisher-id">nutrients-17-02743</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>Nutritional Intervention for Sj&#246;gren Disease: A Systematic Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Castro</surname><given-names initials="FLADL">Fernanda Luiza Ara&#250;jo de Lima</given-names></name><xref rid="af1-nutrients-17-02743" ref-type="aff">1</xref><xref rid="fn1-nutrients-17-02743" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Heredia</surname><given-names initials="JE">Joyce Elisa</given-names></name><xref rid="af2-nutrients-17-02743" ref-type="aff">2</xref><xref rid="fn1-nutrients-17-02743" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schuch</surname><given-names initials="LF">Lauren Frenzel</given-names></name><xref rid="af3-nutrients-17-02743" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6599-3950</contrib-id><name name-style="western"><surname>de Arruda</surname><given-names initials="JAA">Jos&#233; Alcides Almeida</given-names></name><xref rid="af1-nutrients-17-02743" ref-type="aff">1</xref><xref rid="af4-nutrients-17-02743" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6013-9344</contrib-id><name name-style="western"><surname>Castro</surname><given-names initials="MAA">Maur&#237;cio Augusto Aquino</given-names></name><xref rid="af1-nutrients-17-02743" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5535-3223</contrib-id><name name-style="western"><surname>Calderaro</surname><given-names initials="DC">D&#233;bora Cerqueira</given-names></name><xref rid="af5-nutrients-17-02743" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7423-9802</contrib-id><name name-style="western"><surname>de Oliveira</surname><given-names initials="MC">Marina Chaves</given-names></name><xref rid="af2-nutrients-17-02743" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7820-4749</contrib-id><name name-style="western"><surname>de Sousa</surname><given-names initials="SF">S&#237;lvia Ferreira</given-names></name><xref rid="af1-nutrients-17-02743" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9623-7835</contrib-id><name name-style="western"><surname>Silva</surname><given-names initials="TA">Tarc&#237;lia Aparecida</given-names></name><xref rid="af1-nutrients-17-02743" ref-type="aff">1</xref><xref rid="c1-nutrients-17-02743" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Malaguarnera</surname><given-names initials="L">Lucia</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-nutrients-17-02743"><label>1</label>Department of Oral Surgery, Pathology, and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Av. Pres. Ant&#244;nio Carlos, 6627, Room 3204, Belo Horizonte 31270-910, Brazil; <email>fernandaluiza.alc@gmail.com</email> (F.L.A.d.L.C.); <email>alcides_almeida@hotmail.com</email> (J.A.A.d.A.); <email>mauricioaacastro@gmail.com</email> (M.A.A.C.); <email>silviafsousa@yahoo.com.br</email> (S.F.d.S.)</aff><aff id="af2-nutrients-17-02743"><label>2</label>Immunometabolism, Department of Nutrition, School of Nursing, Universidade Federal de Minas Gerais, Belo Horizonte 31270-910, Brazil; <email>joyceheredia.jh@gmail.com</email> (J.E.H.); <email>marina.cdoliveira@gmail.com</email> (M.C.d.O.)</aff><aff id="af3-nutrients-17-02743"><label>3</label>Molecular Pathology Area, School of Dentistry, Universidad de la Rep&#250;blica (UDELAR), Montevideo 14600, Uruguay; <email>laurenfrenzel@gmail.com</email></aff><aff id="af4-nutrients-17-02743"><label>4</label>Department of Oral Diagnosis and Pathology, School of Dentistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil</aff><aff id="af5-nutrients-17-02743"><label>5</label>Departament of Locomotor System, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte 31270-910, Brazil; <email>dccalderaro@gmail.com</email></aff><author-notes><corresp id="c1-nutrients-17-02743"><label>*</label>Correspondence: <email>silva.tarcilia@gmail.com</email> or <email>tarcilia@ufmg.br</email></corresp><fn id="fn1-nutrients-17-02743"><label>&#8224;</label><p>These authors contributed equally to this study.</p></fn></author-notes><pub-date pub-type="epub"><day>25</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>17</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">495755</issue-id><elocation-id>2743</elocation-id><history><date date-type="received"><day>22</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>16</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>25</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nutrients-17-02743.pdf"/><abstract><p><bold>Background/Objectives:</bold> The impact of nutritional interventions on Sj&#246;gren disease (SD) remains uncertain, and no standardized guidelines currently exist for managing its <italic toggle="yes">sicca</italic> symptoms. This systematic review evaluated the effects of dietary interventions on the symptoms of dry mouth and dry eyes in individuals with SD. <bold>Methods:</bold> Electronic searches were performed in four databases, supplemented by manual searches and searches of the gray literature. Both human and animal studies were included. The methodological quality of the selected studies was appraised, and the data were analyzed descriptively. <bold>Results:</bold> A total of nineteen studies (ten in humans and nine in animal models) were included. The treatments evaluated were dietary supplements, vitamins, medicinal herbs, and specially modified diets. The primary outcomes assessed included unstimulated and stimulated whole salivary flow rates, salivary-gland inflammation, and ocular dryness (Schirmer test). In animal models of SD, interventions such as caloric restriction, gluten-free diets, low-fat diets, and supplements (e.g., resveratrol, triptolide, and <italic toggle="yes">Lycium barbarum</italic> polysaccharide) were associated with increased salivary flow and reduced glandular inflammation. Conversely, diets rich in saturated fats were associated with reduced salivary flow and increased lymphocytic infiltration in salivary glands. Human studies yielded mixed results, with some reporting improvements in salivation following interventions with vitamins, herbal supplements, gluten-free diets, liquid diets, and whole-food, plant-based diets. <bold>Conclusions:</bold> Although dietary management may alleviate <italic toggle="yes">sicca</italic> symptoms and improve nutritional status in SD, the current evidence is insufficient to support specific recommendations for the management of oral symptoms.</p></abstract><kwd-group><kwd>diet</kwd><kwd>food</kwd><kwd>nutrition</kwd><kwd>Sj&#246;gren disease</kwd><kwd>Sj&#246;gren&#8217;s syndrome</kwd><kwd>xerostomia</kwd></kwd-group><funding-group><award-group><funding-source>Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado de Minas Gerais</funding-source><award-id>APQ-03440-22</award-id></award-group><funding-statement>The study was financed by Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado de Minas Gerais (FAPEMIG; APQ-03440-22).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-17-02743"><title>1. Introduction</title><p>Sj&#246;gren disease (SD) is an autoimmune condition that primarily affects the salivary and lacrimal glands, leading to inflammation and resulting in symptoms such as dry mouth and dry eyes [<xref rid="B1-nutrients-17-02743" ref-type="bibr">1</xref>]. Its pathogenesis reflects a multifactorial process involving genetic, environmental, and hormonal factors that collectively drive a lymphocyte-mediated immune response [<xref rid="B2-nutrients-17-02743" ref-type="bibr">2</xref>,<xref rid="B3-nutrients-17-02743" ref-type="bibr">3</xref>,<xref rid="B4-nutrients-17-02743" ref-type="bibr">4</xref>]. Three key pathological events characterize SD: (i) an initial triggering phase influenced by genetic susceptibility, hormonal modulation, and environmental exposures; (ii) epithelial cell dysregulation within the salivary glands; and (iii) chronic inflammation marked by lymphocytic infiltration, B-cell hyperactivity, and the production of anti-SSA/Ro and anti-SSB/La autoantibodies. These mechanisms contribute to sustained tissue damage and potential systemic involvement [<xref rid="B2-nutrients-17-02743" ref-type="bibr">2</xref>].</p><p>SD predominantly affects middle-aged women [<xref rid="B5-nutrients-17-02743" ref-type="bibr">5</xref>]. Although not typically life-threatening, SD has no cure and may lead to systemic complications involving the pulmonary, renal, and vascular systems, as well as an increased risk of lymphoma [<xref rid="B1-nutrients-17-02743" ref-type="bibr">1</xref>,<xref rid="B6-nutrients-17-02743" ref-type="bibr">6</xref>]. Additionally, SD frequently coexists with other autoimmune diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) [<xref rid="B3-nutrients-17-02743" ref-type="bibr">3</xref>,<xref rid="B5-nutrients-17-02743" ref-type="bibr">5</xref>]. Treatment primarily focuses on symptom management, including salivary substitutes, stimulants, and artificial tears for <italic toggle="yes">sicca</italic> symptoms. In cases of systemic involvement, therapeutic strategies involve immunosuppressive and immunomodulatory agents, such as corticosteroids, methotrexate, mycophenolate mofetil, and biologics targeting B cells [<xref rid="B7-nutrients-17-02743" ref-type="bibr">7</xref>,<xref rid="B8-nutrients-17-02743" ref-type="bibr">8</xref>].</p><p>The reduction in salivary flow due to glandular damage is a common complaint that significantly impacts quality of life and oral health, increasing the risk of dental caries, fungal infections, and difficulties in eating [<xref rid="B9-nutrients-17-02743" ref-type="bibr">9</xref>,<xref rid="B10-nutrients-17-02743" ref-type="bibr">10</xref>,<xref rid="B11-nutrients-17-02743" ref-type="bibr">11</xref>]. Patients with SD may experience altered or diminished perception of smell and taste, challenges with chewing and swallowing, and dehydration of food, further impairing nutrient intake and dietary habits [<xref rid="B12-nutrients-17-02743" ref-type="bibr">12</xref>,<xref rid="B13-nutrients-17-02743" ref-type="bibr">13</xref>]. The role of diet in managing autoimmune diseases has been widely reported [<xref rid="B14-nutrients-17-02743" ref-type="bibr">14</xref>,<xref rid="B15-nutrients-17-02743" ref-type="bibr">15</xref>], including in SD [<xref rid="B16-nutrients-17-02743" ref-type="bibr">16</xref>,<xref rid="B17-nutrients-17-02743" ref-type="bibr">17</xref>,<xref rid="B18-nutrients-17-02743" ref-type="bibr">18</xref>,<xref rid="B19-nutrients-17-02743" ref-type="bibr">19</xref>,<xref rid="B20-nutrients-17-02743" ref-type="bibr">20</xref>]. However, studies on nutritional interventions to alleviate dryness-related symptoms remain scarce [<xref rid="B13-nutrients-17-02743" ref-type="bibr">13</xref>,<xref rid="B16-nutrients-17-02743" ref-type="bibr">16</xref>]. Consequently, there are currently no established consensus guidelines or protocols to effectively relieve symptoms and improve the nutritional well-being of individuals with SD.</p><p>The purpose of the present study was to synthesize the available data on nutritional interventions targeting clinical features, oral and ocular symptoms, and overall outcomes in individuals with SD. These findings may aid multidisciplinary teams in providing more comprehensive healthcare for patients with SD.</p></sec><sec sec-type="methods" id="sec2-nutrients-17-02743"><title>2. Methods</title><sec id="sec2dot1-nutrients-17-02743"><title>2.1. Eligibility Criteria</title><p>Articles examining nutritional interventions and their outcomes related to oral and ocular dryness in SD were included. The group of eligible study designs comprised case reports, case series, randomized controlled trials (RCT), and experimental studies using animal models. The search was restricted to English-language publications, excluding narrative reviews and inaccessible articles.</p></sec><sec id="sec2dot2-nutrients-17-02743"><title>2.2. Databases and Search Strategy</title><p>Searches were conducted in PubMed, Embase, Web of Science, and Scopus in September 2023 and updated in July 2025. Search terms were combined using the Boolean operators &#8220;OR&#8221;, &#8220;AND&#8221;, and &#8220;NOT&#8221;. No restrictions were applied regarding the publication period. The full search strategy is detailed in <xref rid="app1-nutrients-17-02743" ref-type="app">Supplementary File S1</xref>. Duplicate references identified across databases were removed using Endnote (Clarivate Analytics, Toronto, ON, Canada). Additionally, a manual search was performed by cross-checking reference lists. The gray literature was also assessed, using Google Scholar, with the search limited to the first 200 records [<xref rid="B21-nutrients-17-02743" ref-type="bibr">21</xref>].</p></sec><sec id="sec2dot3-nutrients-17-02743"><title>2.3. Selection Process and Data Extraction</title><p>Two authors (F.L.A.L.C. and J.E.H.) independently and blindly screened titles and abstracts. Full-text articles meeting the eligibility criteria were included. If the title or abstract was unclear, the full article was reviewed to determine inclusion or exclusion. Discrepancies were resolved by consensus or, if necessary, in consultation with a third author (L.F.S.).</p><p>Data were independently extracted by two authors (F.L.A.L.C. and J.E.H.) using a standardized form. For human studies, the following information was collected: authors&#8217; names, year of publication, country, sample size, clinical features of SD, nutritional intervention, duration of intervention, and outcomes related to dryness symptoms. For animal studies, data were gathered on the specific animal models used (e.g., strain, age, and sex), the nutritional intervention applied, and the histological evaluation of salivary glands to assess the outcomes related to SD.</p></sec><sec id="sec2dot4-nutrients-17-02743"><title>2.4. Quality Assessment</title><p>Two authors (F.L.A.L.C. and J.E.H.) independently assessed the methodological quality of the studies. The Joanna Briggs Institute (JBI) critical appraisal tools were used for clinical studies, including case reports [<xref rid="B22-nutrients-17-02743" ref-type="bibr">22</xref>], case-control studies [<xref rid="B22-nutrients-17-02743" ref-type="bibr">22</xref>], and randomized controlled trials [<xref rid="B23-nutrients-17-02743" ref-type="bibr">23</xref>]. Animal studies were evaluated using the SYRCLE Risk of Bias tool [<xref rid="B24-nutrients-17-02743" ref-type="bibr">24</xref>]. The assessment focused on key aspects such as study design, risk of bias, confounding variables, sample size, outcome measurements, and result reproducibility. Studies were evaluated according to the specific parameters applicable to each study type. Any discrepancies between the two authors were resolved through a discussion with a third author (L.F.S.), which lasted until consensus was reached.</p></sec><sec id="sec2dot5-nutrients-17-02743"><title>2.5. Data Analysis</title><p>The data were tabulated in Microsoft Office Excel 2019 (Microsoft<sup>&#174;</sup>, Redmond, WA, USA) and analyzed descriptively.</p></sec><sec id="sec2dot6-nutrients-17-02743"><title>2.6. Protocol and Registration</title><p>This systematic review was conducted following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [<xref rid="B25-nutrients-17-02743" ref-type="bibr">25</xref>]. A protocol was drafted and registered with the National Institute for Health Research International Prospective Register of Systematic Reviews (PROSPERO; No. CRD42024517376).</p></sec></sec><sec sec-type="results" id="sec3-nutrients-17-02743"><title>3. Results</title><sec id="sec3dot1-nutrients-17-02743"><title>3.1. Study Selection and General Characteristics of Included Studies</title><p>The electronic searches initially identified 775 articles. After applying the eligibility criteria, 16 studies were selected. Additionally, three studies were identified through manual searches and included in the final analysis. <xref rid="nutrients-17-02743-f001" ref-type="fig">Figure 1</xref> depicts the flowchart outlining the article selection process. Summaries of the data extracted from the nine studies involving animal models and the ten human studies are displayed in <xref rid="nutrients-17-02743-t001" ref-type="table">Table 1</xref> and <xref rid="nutrients-17-02743-t002" ref-type="table">Table 2</xref>, respectively.</p></sec><sec id="sec3dot2-nutrients-17-02743"><title>3.2. Animal Studies</title><p>The animal studies were published between 1989 and 2024 and conducted in eight countries. To recapitulate the clinical features of SD, different mice lineages were used, including female hybrid New Zealand mice (NZB &#215; NZW) [<xref rid="B26-nutrients-17-02743" ref-type="bibr">26</xref>,<xref rid="B27-nutrients-17-02743" ref-type="bibr">27</xref>], non-obese diabetic (NOD) mice (or mouse) [<xref rid="B28-nutrients-17-02743" ref-type="bibr">28</xref>,<xref rid="B29-nutrients-17-02743" ref-type="bibr">29</xref>,<xref rid="B30-nutrients-17-02743" ref-type="bibr">30</xref>,<xref rid="B31-nutrients-17-02743" ref-type="bibr">31</xref>,<xref rid="B32-nutrients-17-02743" ref-type="bibr">32</xref>,<xref rid="B33-nutrients-17-02743" ref-type="bibr">33</xref>], and male IL-14&#945; transgenic mice [<xref rid="B20-nutrients-17-02743" ref-type="bibr">20</xref>]. Nutritional interventions were administered either orally or via gavage. Studies have evaluated the effects of resveratrol, triptolide, and <italic toggle="yes">Lycium barbarum</italic> polysaccharide (LBP), as well as dietary modifications, including high-saturated- or high-unsaturated-fat diets, gluten-free (GF) diets, alternate-day fasting (ADF), and caloric restriction (CR). The durations of these dietary interventions ranged from 3 weeks to 11 months.</p><p>The primary outcomes assessed in most studies included unstimulated salivary flow, the degree of salivary-gland inflammation as determined through histopathological analysis, and the Schirmer test. Zhang et al. [<xref rid="B20-nutrients-17-02743" ref-type="bibr">20</xref>] evaluated the effects of a diet containing 60 kcal% fat over an 11-month period on the relevant parameters. Swanson et al. [<xref rid="B26-nutrients-17-02743" ref-type="bibr">26</xref>] compared the impact of a high-saturated-fat diet, a high-unsaturated-fat diet, and a low-fat diet over a 3-month period. Animals fed high-fat diets exhibited increased infiltration of inflammatory cells and structural damage to the salivary and lacrimal glands [<xref rid="B20-nutrients-17-02743" ref-type="bibr">20</xref>,<xref rid="B26-nutrients-17-02743" ref-type="bibr">26</xref>]. In contrast, those receiving the low-fat diet showed reduced lymphocytic infiltration and better preservation of glandular architecture. Tear secretion, assessed using the Schirmer test, was significantly higher in the low-fat group compared to both high-fat groups, indicating superior lacrimal gland function [<xref rid="B20-nutrients-17-02743" ref-type="bibr">20</xref>,<xref rid="B26-nutrients-17-02743" ref-type="bibr">26</xref>]. Conversely, CR strategies, such as ADF [<xref rid="B32-nutrients-17-02743" ref-type="bibr">32</xref>,<xref rid="B33-nutrients-17-02743" ref-type="bibr">33</xref>] and diets with a 40% calorie reduction [<xref rid="B27-nutrients-17-02743" ref-type="bibr">27</xref>], demonstrated positive effects, improving salivation and reducing salivary-gland inflammation. A GF diet, in which gluten-containing ingredients were replaced with meat protein for 13 weeks, resulted in reduced salivary-gland inflammation [<xref rid="B30-nutrients-17-02743" ref-type="bibr">30</xref>].</p><p>Plant-derived supplements, such as resveratrol, triptolide, and LBP, demonstrated beneficial effects in animal models of SD compared to controls [<xref rid="B28-nutrients-17-02743" ref-type="bibr">28</xref>,<xref rid="B29-nutrients-17-02743" ref-type="bibr">29</xref>,<xref rid="B31-nutrients-17-02743" ref-type="bibr">31</xref>]. Resveratrol and triptolide were administered via gastric gavage for 16 weeks and 90 days, respectively, and both were compared to a control group. LBP was orally administered over a 12-week period, with one group receiving a high dose and another a low dose. These groups were compared to a control group and a group receiving low-dose recombinant human IL-2. <xref rid="nutrients-17-02743-f002" ref-type="fig">Figure 2</xref>A summarizes the data obtained from these animal studies.</p></sec><sec id="sec3dot3-nutrients-17-02743"><title>3.3. Human Studies</title><sec id="sec3dot3dot1-nutrients-17-02743"><title>3.3.1. Vitamin and Mineral Supplements</title><p>Raffle [<xref rid="B34-nutrients-17-02743" ref-type="bibr">34</xref>] investigated the effects of vitamin A, ferrous sulfate, and Beplex capsules (containing thiamine hydrochloride, riboflavin, and nicotinic acid) in a patient with SD symptoms. The study did not include objective measurements of salivary or tear flow, but reported no improvement in oral health conditions, despite the patient&#8217;s subjective perception of improvement.</p><p>Horrobin and Campbell [<xref rid="B36-nutrients-17-02743" ref-type="bibr">36</xref>] evaluated the effects of vitamin C, pyridoxine, and Evening Primrose Oil capsules on SD patients. This 12-month intervention significantly improved tear and saliva production in five individuals. However, McKendry [<xref rid="B37-nutrients-17-02743" ref-type="bibr">37</xref>] reported that the same nutrients were ineffective in managing oral and ocular dryness symptoms in SD.</p><p>Liao et al. [<xref rid="B43-nutrients-17-02743" ref-type="bibr">43</xref>] investigated the effects of potassium citrate and vitamin D, reporting that the patient experienced no <italic toggle="yes">sicca</italic> symptoms following treatment. However, the study did not include objective measurements to substantiate these reported improvements.</p></sec><sec id="sec3dot3dot2-nutrients-17-02743"><title>3.3.2. GF and Special Diets</title><p>Maclaurin et al. [<xref rid="B35-nutrients-17-02743" ref-type="bibr">35</xref>] documented the effects of a GF diet combined with vitamin B12, folic acid, calcium, and other vitamins over a two-month period. This regimen improved tear secretion, as measured by the Schirmer test, and overall well-being; however, the dry mouth symptoms remained unchanged.</p><p>Goldner and Staffier [<xref rid="B44-nutrients-17-02743" ref-type="bibr">44</xref>] evaluated the effects of a whole-food, plant-based (WFPB) diet, consisting of raw foods, leafy greens, vegetables, water, and polyunsaturated fatty acids (PUFAs), over a four-week period. The study reported improvements in both dry mouth and dry eyes in three patients with SD. However, no objective tests for tear or salivary flow were conducted.</p></sec><sec id="sec3dot3dot3-nutrients-17-02743"><title>3.3.3. Liquid and Modified Diets</title><p>Peen et al. [<xref rid="B40-nutrients-17-02743" ref-type="bibr">40</xref>] investigated the effects of a liquid diet that eliminated the need for chewing and found a significant increase in unstimulated whole salivary flow rate (UWSFR), which rose from 1.18 mL/15 min to 1.70 mL/15 min over four weeks. Similar improvements were observed in tear flow, as measured by the Schirmer test, while no such effects were noted in the control group.</p></sec><sec id="sec3dot3dot4-nutrients-17-02743"><title>3.3.4. Herbal and Specialized Supplements</title><p>Pedersen et al. [<xref rid="B38-nutrients-17-02743" ref-type="bibr">38</xref>] investigated Longo Vital, a herbal-based vitamin supplement. The study showed a significant increase in UWSFR in one group after four months. Results regarding stimulated salivary flow were mixed, with improvements observed during different phases of treatment. No significant changes were observed in dry eye symptoms.</p><p>Singh et al. [<xref rid="B42-nutrients-17-02743" ref-type="bibr">42</xref>] evaluated the effects of TheraTears Nutrition, a supplement containing flaxseed oil, eicosapentaenoic acid, docosahexaenoic acid, and vitamin E, providing a total of 1750 mg of omega-3. The supplement significantly improved UWSFR and stimulated salivary flow; however, these improvements were not significantly different from those observed in the placebo group. Additionally, no significant changes were noted in Schirmer test results for either group. Another study conducted by Al-Rawi et al. [<xref rid="B45-nutrients-17-02743" ref-type="bibr">45</xref>] evaluated the effects of omega-3 supplementation over a two-month period in patients with SD and reported improvements in UWSFR, Schirmer test results, and symptoms of both oral and ocular dryness. <xref rid="nutrients-17-02743-f002" ref-type="fig">Figure 2</xref>B summarizes the nutritional interventions conducted in humans.</p></sec></sec><sec id="sec3dot4-nutrients-17-02743"><title>3.4. Critical Appraisal</title><p>Critical appraisal of the case reports revealed that most articles provided a clear description of the patient&#8217;s demographic characteristics, medical history, and clinical timeline. Additionally, the majority adequately detailed the diagnostic tests or assessment methods used, as well as the interventions, treatment procedures, and post-intervention clinical outcomes. However, two articles did not include information on the patient&#8217;s contemporaneous clinical condition. Also, most reports failed to identify or describe adverse events or unexpected outcomes. Nevertheless, all articles presented key takeaway lessons. The case&#8211;control study lacked clarity in defining the case and control groups, assessing outcomes, and determining the exposure period. Furthermore, it did not outline strategies for managing confounding factors. Two randomized clinical trials raised concerns regarding participant randomization, treatment group allocation, blinding of assessors, outcome measurement, and statistical analysis. In contrast, a third trial was conducted with greater methodological rigor and did not present major deficiencies. <xref rid="app1-nutrients-17-02743" ref-type="app">Supplementary Files S2&#8211;S4</xref> provide details on the critical appraisal of human studies. The quality assessment of animal studies identified multiple articles with unclear information on various evaluatory criteria (<xref rid="app1-nutrients-17-02743" ref-type="app">Supplementary File S5</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-nutrients-17-02743"><title>4. Discussion</title><p>SD is a chronic systemic autoimmune disease characterized by severe dry mouth, which impairs chewing, swallowing, and overall nutritional status [<xref rid="B16-nutrients-17-02743" ref-type="bibr">16</xref>,<xref rid="B46-nutrients-17-02743" ref-type="bibr">46</xref>]. While evidence on the role of diet in SD management remains limited, it is well established that nutritional status influences the progression of rheumatic and inflammatory diseases [<xref rid="B47-nutrients-17-02743" ref-type="bibr">47</xref>,<xref rid="B48-nutrients-17-02743" ref-type="bibr">48</xref>]. Healthy dietary patterns can regulate gut microbiota, strengthen barriers against harmful antigens, reduce chronic inflammation, and alleviate autoimmune disease symptoms [<xref rid="B49-nutrients-17-02743" ref-type="bibr">49</xref>]. This systematic review analyzed both observational and experimental studies in humans and animal models, focusing on nutritional interventions for SD. Various dietary components, including plant-derived compounds, vitamins, omega-3 fatty acids, and specific dietary patterns, demonstrated varying degrees of efficacy in alleviating oral symptoms and reducing salivary-gland inflammation. However, the heterogeneity of study designs and outcome measures, along with the limited number of high-quality human studies, restricts the ability to derive specific nutritional recommendations.</p><p>Plant-derived compounds such as resveratrol and triptolide have been extensively studied for their immunomodulatory properties. Resveratrol regulates T-cell differentiation and inhibits pro-inflammatory cytokines through the AMPK and NF-&#954;B pathways [<xref rid="B50-nutrients-17-02743" ref-type="bibr">50</xref>], while triptolide modulates NF-&#954;B, MAPK, IL-6/STAT3, and SOCS3 signaling pathways [<xref rid="B51-nutrients-17-02743" ref-type="bibr">51</xref>,<xref rid="B52-nutrients-17-02743" ref-type="bibr">52</xref>]. Animal studies have demonstrated the therapeutic potential of these compounds, showing improvements in hyposalivation and reductions in salivary-gland inflammation. Additionally, resveratrol increased IL-10 expression, whereas triptolide inhibited JAK/STAT and NF-&#954;B signaling [<xref rid="B28-nutrients-17-02743" ref-type="bibr">28</xref>,<xref rid="B29-nutrients-17-02743" ref-type="bibr">29</xref>]. Nevertheless, neither compound has been tested for its effects on dry eye symptoms. LBP, extracted from the <italic toggle="yes">goji berry</italic>, has also exhibited antioxidant and anti-inflammatory properties, improving dry mouth symptoms in animal models [<xref rid="B31-nutrients-17-02743" ref-type="bibr">31</xref>,<xref rid="B53-nutrients-17-02743" ref-type="bibr">53</xref>]. However, no studies have evaluated its impact on dry eye symptoms.</p><p>Recent evidence suggests that dysregulation of lipid metabolism plays a critical role in autoimmune diseases, including SD. Patients with SD frequently exhibit dyslipidemia, characterized by elevated levels of total cholesterol, LDL, and triglycerides, along with reduced HDL levels [<xref rid="B54-nutrients-17-02743" ref-type="bibr">54</xref>]. These lipid imbalances have been associated with increased systemic inflammation and glandular dysfunction. In the present review, we observed that nutritional interventions, such as caloric restriction and plant-derived compounds, demonstrated promising effects in reducing glandular inflammation. These findings may be partially attributed to their role in modulating lipid metabolism, as excessive lipid deposition in exocrine tissues has been proposed as not merely as a consequence of the disease, but a potential trigger for inflammation [<xref rid="B54-nutrients-17-02743" ref-type="bibr">54</xref>].</p><p>Vitamins play a crucial role in immune regulation and cellular metabolism, with deficiencies linked to the development of autoimmune diseases [<xref rid="B55-nutrients-17-02743" ref-type="bibr">55</xref>]. Vitamins A, D, and E influence various aspects of both the innate and adaptive immune systems, contributing to cellular regulation and metabolism. Deficiencies in vitamins A, D, and E have been implicated in the pathogenesis of autoimmune disorders [<xref rid="B50-nutrients-17-02743" ref-type="bibr">50</xref>,<xref rid="B55-nutrients-17-02743" ref-type="bibr">55</xref>,<xref rid="B56-nutrients-17-02743" ref-type="bibr">56</xref>]. Szodoray et al. [<xref rid="B17-nutrients-17-02743" ref-type="bibr">17</xref>] investigated vitamin A, D, and E levels in patients with SD, reporting significantly lower vitamin A levels in individuals with more advanced disease compared to those with milder forms. In this context, reduced vitamin A levels may contribute to disease progression, as patients with lower serum levels exhibited more severe symptoms. Vitamin C also plays a role in immune function and autoimmunity [<xref rid="B57-nutrients-17-02743" ref-type="bibr">57</xref>]; however, evidence regarding its benefits in managing SD and <italic toggle="yes">sicca</italic> symptoms remains inconclusive. Notably, one of the vitamin-based supplements evaluated (Longo Vital) was associated with adverse effects, including constipation, pruritus, skin rash, nausea, and exacerbation of psoriasis [<xref rid="B38-nutrients-17-02743" ref-type="bibr">38</xref>].</p><p>Omega-3 polyunsaturated fatty acids have demonstrated anti-inflammatory effects in autoimmune diseases by reducing oxidative stress and modulating pro-inflammatory cytokines [<xref rid="B58-nutrients-17-02743" ref-type="bibr">58</xref>,<xref rid="B59-nutrients-17-02743" ref-type="bibr">59</xref>]. Patients with SD, in particular, may have insufficient omega-3 intake, which has been associated with worsening disease symptoms, including reduced salivary flow [<xref rid="B60-nutrients-17-02743" ref-type="bibr">60</xref>]. A recent literature review [<xref rid="B61-nutrients-17-02743" ref-type="bibr">61</xref>] evaluating the use of PUFAs, including omega-3, indicated potential benefits for keratoconjunctivitis and for the modulation of inflammatory markers, such as total plasma phospholipid levels, erythrocyte membrane fatty acid composition, and ocular surface inflammation. Supporting these observations, Al-Rawi et al. [<xref rid="B45-nutrients-17-02743" ref-type="bibr">45</xref>] reported improvements in both salivation and tear flow following two months of omega-3 supplementation. Additionally, Singh et al. [<xref rid="B42-nutrients-17-02743" ref-type="bibr">42</xref>] documented that omega-3 supplementation increased salivary flow and improved periodontitis by reducing probing depth in patients with SD. From a clinical perspective, while a previous systematic review found no evidence of an increased risk of periodontitis in SD patients, it highlighted that these patients are more prone to dental caries, compared to individuals without SD [<xref rid="B62-nutrients-17-02743" ref-type="bibr">62</xref>]. Mechanistically, periodontitis may still be linked to SD through shared inflammatory pathways and dysregulated immune responses. This suggests that improving periodontal health could potentially alleviate other systemic symptoms of the disease.</p><p>Two studies, one in humans and one in mice, evaluated the effects of a GF diet on SD, but neither reported positive outcomes concerning oral health [<xref rid="B30-nutrients-17-02743" ref-type="bibr">30</xref>,<xref rid="B35-nutrients-17-02743" ref-type="bibr">35</xref>]. Gluten is a protein known to trigger adverse effects in individuals with celiac disease, and it has been implicated in exacerbating symptoms of autoimmune disorders [<xref rid="B63-nutrients-17-02743" ref-type="bibr">63</xref>,<xref rid="B64-nutrients-17-02743" ref-type="bibr">64</xref>]. A recent review found that GF diets alleviated symptoms in many patients with non-celiac autoimmune diseases, suggesting potential benefits for individuals with autoimmune conditions [<xref rid="B65-nutrients-17-02743" ref-type="bibr">65</xref>]. However, studies assessing this dietary approach in SD did not find improvements in oral symptoms, despite reporting other benefits, such as reduced pancreatic insulitis and decreased lung and spleen weight in mice, as well as enhanced general well-being and increased tear secretion, as confirmed by the Schirmer test, in humans [<xref rid="B30-nutrients-17-02743" ref-type="bibr">30</xref>,<xref rid="B35-nutrients-17-02743" ref-type="bibr">35</xref>].</p><p>The modern dietary pattern, particularly in Western countries, is characterized by the consumption of ultra-processed foods rich in sugar and fat [<xref rid="B66-nutrients-17-02743" ref-type="bibr">66</xref>]. Such diets are known to induce gut microbiota dysbiosis, which promotes inflammatory changes, enhances autoantibody production, and contributes to the development of autoimmune diseases [<xref rid="B67-nutrients-17-02743" ref-type="bibr">67</xref>,<xref rid="B68-nutrients-17-02743" ref-type="bibr">68</xref>]. Emerging evidence suggests a link between the gut microbiota and salivary-gland function, known as the gut&#8211;salivary-gland axis [<xref rid="B69-nutrients-17-02743" ref-type="bibr">69</xref>]. Dysbiosis is associated with systemic inflammation, potentially driving autoimmune mechanisms in SD [<xref rid="B70-nutrients-17-02743" ref-type="bibr">70</xref>]. Dietary interventions aimed at modulating the microbiota (e.g., probiotics and prebiotics) may help regulate autoimmune responses and alleviate dryness symptoms, warranting further investigation. Interestingly, one study found that patients with SD who also had metabolic syndrome, i.e., a cluster of cardiovascular risk factors influenced by nutrition, genetics, and gut microbiota [<xref rid="B71-nutrients-17-02743" ref-type="bibr">71</xref>], exhibited increased body mass index (BMI), waist circumference, visceral fat, hypertension, and diabetes, as well as elevated cholesterol levels [<xref rid="B72-nutrients-17-02743" ref-type="bibr">72</xref>]. Nevertheless, other studies did not demonstrate significantly higher BMI values or an increased prevalence of obesity in SD patients [<xref rid="B73-nutrients-17-02743" ref-type="bibr">73</xref>]. These inconsistencies, however, highlight the importance of tailoring dietary strategies to specific patient subgroups to enhance treatment efficacy and optimize clinical outcomes.</p><p>A diet rich in fruits, vegetables, legumes, fish, grains, and olive oil&#8212;commonly referred to as the Mediterranean or plant-based diet&#8212;has been shown to prevent or mitigate various chronic conditions [<xref rid="B74-nutrients-17-02743" ref-type="bibr">74</xref>,<xref rid="B75-nutrients-17-02743" ref-type="bibr">75</xref>]. Reducing the intake of processed and high-fat foods while adopting a balanced dietary pattern can alleviate inflammation and musculoskeletal pain in patients with RA and SLE [<xref rid="B76-nutrients-17-02743" ref-type="bibr">76</xref>,<xref rid="B77-nutrients-17-02743" ref-type="bibr">77</xref>]. Three of the studies included in the present review addressed such dietary influences. One reported that animals fed diets high in saturated or unsaturated fats exhibited more pronounced lymphocytic infiltration in the salivary glands compared to those on a low-fat diet [<xref rid="B26-nutrients-17-02743" ref-type="bibr">26</xref>]. Another found that high-fat diets reduced salivary secretion, increased inflammation, and worsened gut dysbiosis [<xref rid="B20-nutrients-17-02743" ref-type="bibr">20</xref>]. Although no human studies have directly assessed the impact of unbalanced diets on salivary-gland function, one plant-based diet intervention revealed symptomatic improvement, with some patients discontinuing medications; however, outcomes were based solely on self-reported data, without objective validation [<xref rid="B44-nutrients-17-02743" ref-type="bibr">44</xref>]. Recently, Chaaya et al. [<xref rid="B78-nutrients-17-02743" ref-type="bibr">78</xref>] provided human evidence linking higher adherence to the Mediterranean diet with reduced ocular dryness in patients with SD. Moreover, a higher intake of polyunsaturated fatty acids (e.g., omega-3s from fish, nuts, and olive oil) was independently associated with better ocular surface health. Collectively, these findings suggest that unbalanced diets may exacerbate both salivary and ocular symptoms in SD. Although preclinical data support this association [<xref rid="B19-nutrients-17-02743" ref-type="bibr">19</xref>,<xref rid="B73-nutrients-17-02743" ref-type="bibr">73</xref>,<xref rid="B77-nutrients-17-02743" ref-type="bibr">77</xref>], the inclusion of recent clinical evidence reinforces the therapeutic potential of Mediterranean-style dietary strategies.</p><p>Another type of intervention analyzed in this review was based on ADF and CR. Mice subjected to ADF exhibited significantly increased salivary flow and markedly reduced inflammation in the submandibular glands [<xref rid="B32-nutrients-17-02743" ref-type="bibr">32</xref>]. Additionally, ADF has been shown to decrease the expression of markers related to senescence, apoptosis, and inflammation in salivary-gland stem cells [<xref rid="B34-nutrients-17-02743" ref-type="bibr">34</xref>]. These markers are associated with various disorders, including autoimmune diseases such as SD [<xref rid="B79-nutrients-17-02743" ref-type="bibr">79</xref>,<xref rid="B80-nutrients-17-02743" ref-type="bibr">80</xref>,<xref rid="B81-nutrients-17-02743" ref-type="bibr">81</xref>]. Chandrasekar et al. [<xref rid="B27-nutrients-17-02743" ref-type="bibr">27</xref>] conducted a longitudinal study in which animals were evaluated from a young age through advanced stages, and compared an ad libitum diet with a 40% caloric restriction regimen. The authors found that early initiation of caloric restriction prevented inflammation in the salivary glands. However, these two studies did not assess salivary flow [<xref rid="B27-nutrients-17-02743" ref-type="bibr">27</xref>,<xref rid="B33-nutrients-17-02743" ref-type="bibr">33</xref>]. Hunger is believed to modulate immune responses and alleviate symptoms of autoimmune diseases. Food deprivation, as a dietary intervention, has been associated with improved glycemic control, delayed aging, suppression of inflammation, and enhanced overall health [<xref rid="B82-nutrients-17-02743" ref-type="bibr">82</xref>,<xref rid="B83-nutrients-17-02743" ref-type="bibr">83</xref>]. Studies investigating caloric restriction in animal models of multiple sclerosis have demonstrated a downregulation of pro-inflammatory genes, leading to significant symptom improvement [<xref rid="B84-nutrients-17-02743" ref-type="bibr">84</xref>]. Further research is required to assess the safety of this approach and establish an optimal food deprivation regimen.</p><p>Peen et al. [<xref rid="B40-nutrients-17-02743" ref-type="bibr">40</xref>] investigated the effects of a liquid diet, which eliminates chewing, in individuals with SD. Notably, this dietary approach was found to be beneficial, increasing salivary flow after just four days. The study was based on the hypothesis proposed by Humphreys-Beher et al. [<xref rid="B85-nutrients-17-02743" ref-type="bibr">85</xref>], who suggested that salivary-gland stress could be mitigated by reducing neural input to the glands, and that this could be achieved through decreased mastication. However, these findings contrast with those of other studies [<xref rid="B86-nutrients-17-02743" ref-type="bibr">86</xref>,<xref rid="B87-nutrients-17-02743" ref-type="bibr">87</xref>]. A recent literature review compiled multiple studies suggesting that soft diets tend to have a negative impact on the salivary glands [<xref rid="B88-nutrients-17-02743" ref-type="bibr">88</xref>]. The parotid glands were the most affected, exhibiting atrophy, reduced weight, and decreased production of amylase and salivary proteins, whereas the submandibular and sublingual glands remained largely unaffected [<xref rid="B86-nutrients-17-02743" ref-type="bibr">86</xref>,<xref rid="B87-nutrients-17-02743" ref-type="bibr">87</xref>]. Given the limited number of studies assessing diet consistency and its effects on SD, it remains inconclusive whether a liquid diet provides a genuine benefit for patients with dry mouth.</p><p>Nutritional alterations in SD should be considered in light of their impact on the oral microbiome, which may contribute to immune dysregulation and oral dryness. It has been documented that oral dysbiosis is increasingly recognized as central to SD pathophysiology [<xref rid="B89-nutrients-17-02743" ref-type="bibr">89</xref>,<xref rid="B90-nutrients-17-02743" ref-type="bibr">90</xref>]. For instance, <italic toggle="yes">Prevotella melaninogenica</italic> has been associated with pro-inflammatory responses through MHC, CD80, and IFN-&#947; induction [<xref rid="B91-nutrients-17-02743" ref-type="bibr">91</xref>], whereas <italic toggle="yes">Haemophilus parainfluenzae</italic> appears to be protective; i.e., its reduced salivary levels in SD contrast with murine data showing that glandular inoculation restored salivary function, reduced sialoadenitis, and suppressed IFN-&#947;&#8211;producing T cells, with epithelial exposure inhibiting human CD8+ T-cell activation [<xref rid="B92-nutrients-17-02743" ref-type="bibr">92</xref>]. Despite evidence linking dysbiosis to symptom exacerbation, the influence of diet on the oral microbiome in SD remains poorly explored, though dietary composition directly shapes microbial substrates and the production of pro- or anti-inflammatory metabolites [<xref rid="B93-nutrients-17-02743" ref-type="bibr">93</xref>], offering potential insights into mechanisms of chronic inflammation and disease progression.</p><p>As far as we know, this is the first systematic review to comprehensively synthesize information on the role of nutrition in the dryness-related aspects of SD, drawing from both animal models and human studies. A key strength of this review lies in its rigorous, protocol-registered methodology. The inclusion of animal studies was intentional and justified by their capacity to elucidate mechanistic and immunometabolic pathways that remain unexplored in human cohorts. Although preclinical findings are not directly generalizable, they offer critical translational insights in a field where clinical trials remain scarce. Conversely, limitations of the present systematic review should be acknowledged. First, many of the included studies lacked robust methodological details and comprehensive data reporting, which limited the depth of evidence synthesis. Second, there was marked heterogeneity in study designs, including variability in population characteristics, types and durations of nutritional interventions, and outcome measures (e.g., unstimulated vs. stimulated salivary flow, and differing Schirmer test methodologies). This variability hinders direct comparisons across studies, and the feasibility of meta-analyses. Third, evolving classification criteria for SD in recent years may have influenced patient selection and stratification across studies. Additionally, the absence of standardized tools for assessing dryness parameters further limits the interpretability of results. Future randomized clinical trials and well-designed cohort studies are essential to advance this field. Such studies should adopt current diagnostic guidelines [<xref rid="B86-nutrients-17-02743" ref-type="bibr">86</xref>], incorporate parameterized assessments of oral dryness, and apply standardized nutritional interventions [<xref rid="B94-nutrients-17-02743" ref-type="bibr">94</xref>]. Lastly, while animal models effectively recapitulate key aspects of SD pathophysiology and are valuable for exploring the effects of dietary modulation, the extrapolation of these findings to human disease remains limited due to inherent differences in immune regulation, disease progression, and environmental context.</p><p>In summary, several present dietary approaches are promising for SD management. Based on the available evidence, the following nutritional strategies may be considered for recommendation:<list list-type="simple"><list-item><label>-</label><p>High-fat diets (saturated and unsaturated) should be avoided, as they are linked to increased inflammatory infiltration, glandular damage, and inferior Schirmer performance [<xref rid="B20-nutrients-17-02743" ref-type="bibr">20</xref>,<xref rid="B26-nutrients-17-02743" ref-type="bibr">26</xref>].</p></list-item><list-item><label>-</label><p>CR strategies, including alternate-day fasting and ~40% energy reduction, have shown benefits with respect to salivation and inflammation in animal studies [<xref rid="B27-nutrients-17-02743" ref-type="bibr">27</xref>,<xref rid="B32-nutrients-17-02743" ref-type="bibr">32</xref>,<xref rid="B33-nutrients-17-02743" ref-type="bibr">33</xref>].</p></list-item><list-item><label>-</label><p>GF diets have reduced salivary-gland inflammation in animals and improved Schirmer without change in xerostomia in humans [<xref rid="B30-nutrients-17-02743" ref-type="bibr">30</xref>,<xref rid="B35-nutrients-17-02743" ref-type="bibr">35</xref>].</p></list-item><list-item><label>-</label><p>WFPB [<xref rid="B44-nutrients-17-02743" ref-type="bibr">44</xref>] and liquid/modified diets that eliminate mastication are linked with symptom improvement [<xref rid="B40-nutrients-17-02743" ref-type="bibr">40</xref>].</p></list-item><list-item><label>-</label><p>Plant-derived supplements such as resveratrol, triptolide, and <italic toggle="yes">Lycium barbarum</italic> polysaccharide have demonstrated benefits in animal models [<xref rid="B28-nutrients-17-02743" ref-type="bibr">28</xref>,<xref rid="B29-nutrients-17-02743" ref-type="bibr">29</xref>,<xref rid="B31-nutrients-17-02743" ref-type="bibr">31</xref>].</p></list-item></list></p><p>Evidence for vitamins/minerals and other specialized supplements (e.g., vitamin A, iron, Beplex; vitamin C, pyridoxine; potassium citrate with vitamin D; Longo Vital; and omega-3 formulations) remains mixed or limited, with variable results, and one trial showing no advantage over placebo [<xref rid="B34-nutrients-17-02743" ref-type="bibr">34</xref>,<xref rid="B36-nutrients-17-02743" ref-type="bibr">36</xref>,<xref rid="B37-nutrients-17-02743" ref-type="bibr">37</xref>,<xref rid="B38-nutrients-17-02743" ref-type="bibr">38</xref>,<xref rid="B42-nutrients-17-02743" ref-type="bibr">42</xref>,<xref rid="B43-nutrients-17-02743" ref-type="bibr">43</xref>,<xref rid="B45-nutrients-17-02743" ref-type="bibr">45</xref>]. Further research is needed to establish a clear and specific dietary recommendation for patients with SD.</p><p>The present review does not merely reaffirm the broad notion that healthy nutrition contributes to immune homeostasis. Rather, it offers a focused, disease-specific synthesis of dietary strategies that have been tested in the context of SD, particularly in relation to its hallmark features, i.e., exocrine gland dysfunction, salivary hypofunction, and chronic lymphocytic infiltration. By integrating findings from experimental models and clinical studies, we emphasize the role of nutritional interventions (e.g., caloric restriction, omega-3 supplementation, plant-derived immunomodulators, and gut-microbiota-targeting strategies) not as general wellness measures, but as potential modulators of key immunometabolic pathways involved in SD pathogenesis. This conceptual distinction is essential to prevent overgeneralization and to position nutrition as a translational tool in the management of SD, beyond its ancillary role in systemic inflammation.</p></sec><sec sec-type="conclusions" id="sec5-nutrients-17-02743"><title>5. Conclusions</title><p>Dietary management may be a viable strategy for alleviating <italic toggle="yes">sicca</italic> symptoms and improving the nutritional status of individuals with SD. Early studies, including those on GF diets and vitamin supplementation, have yielded mixed results, with no definitive improvements in dry mouth symptoms. Similarly, the effects of individual nutrients and dietary patterns, such as CR and plant-derived compounds, require further investigation. More recent research on WFPB diets, liquid diets, and specific supplements suggests potential benefits. Overall, this systematic review underscores the need for well-designed clinical trials and standardized assessment methods to better understand and optimize nutritional strategies for patients with SD.</p></sec></body><back><ack><title>Acknowledgments</title><p>We would like to thank Funda&#231;&#227;o Carlos Chagas Filho de Amparo &#224; Pesquisa do Estado do Rio de Janeiro (FAPERJ; E-26/200.330/2024; E-26/200.331/2024), Coordena&#231;&#227;o de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior (CAPES; Finance Code 001), and Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico (CNPq; 305077/2021-0).</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-nutrients-17-02743"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/article/10.3390/nu17172743/s1">https://www.mdpi.com/article/10.3390/nu17172743/s1</uri>.</p><supplementary-material id="nutrients-17-02743-s001" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nutrients-17-02743-s001.zip" position="float" orientation="portrait"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>F.L.A.d.L.C., J.E.H. and L.F.S. conceptualized the study. F.L.A.d.L.C. and L.F.S. curated the data. J.A.A.d.A. and D.C.C. performed formal analysis. F.L.A.d.L.C., J.E.H., M.C.d.O. and S.F.d.S. conducted the investigation. F.L.A.d.L.C., J.A.A.d.A. and M.A.A.C. developed the methodology. T.A.S. administered the project. F.L.A.d.L.C. and M.A.A.C. provided resources. D.C.C., M.C.d.O., S.F.d.S. and T.A.S. validated the findings. F.L.A.d.L.C., J.E.H. and J.A.A.d.A. drafted the original manuscript. F.L.A.d.L.C., J.E.H., L.F.S., J.A.A.d.A., M.A.A.C., D.C.C., M.C.d.O., S.F.d.S. and T.A.S. reviewed, edited, and approved the final version of the article. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original contributions presented in this study are included in the article/<xref rid="app1-nutrients-17-02743" ref-type="app">Supplementary Material</xref>. Further inquiries can be directed to the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-nutrients-17-02743"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Price</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Benjamin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bombardieri</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bowman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Carty</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ciurtin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Crampton</surname><given-names>B.</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Giles</surname><given-names>I.</given-names></name><etal/></person-group><article-title>British Society for Rheumatology guideline on management of adult and juvenile onset Sj&#246;gren disease</article-title><source>Rheumatology</source><year>2025</year><volume>64</volume><fpage>409</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/keae152</pub-id><pub-id pub-id-type="pmid">38621708</pub-id><pub-id pub-id-type="pmcid">PMC12013823</pub-id></element-citation></ref><ref id="B2-nutrients-17-02743"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parisis</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chivasso</surname><given-names>C.</given-names></name><name name-style="western"><surname>Perret</surname><given-names>J.</given-names></name><name name-style="western"><surname>Soyfoo</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Delporte</surname><given-names>C.</given-names></name></person-group><article-title>Current state of knowledge on primary Sj&#246;gren&#8217;s syndrome, an autoimmune exocrinopathy</article-title><source>J. Clin. Med.</source><year>2020</year><volume>9</volume><elocation-id>2299</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9072299</pub-id><pub-id pub-id-type="pmid">32698400</pub-id><pub-id pub-id-type="pmcid">PMC7408693</pub-id></element-citation></ref><ref id="B3-nutrients-17-02743"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brito-Zer&#243;n</surname><given-names>P.</given-names></name><name name-style="western"><surname>Baldini</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bootsma</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bowman</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Jonsson</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mariette</surname><given-names>X.</given-names></name><name name-style="western"><surname>Sivils</surname><given-names>K.</given-names></name><name name-style="western"><surname>Theander</surname><given-names>E.</given-names></name><name name-style="western"><surname>Tzioufas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ramos-Casals</surname><given-names>M.</given-names></name></person-group><article-title>Sj&#246;gren syndrome</article-title><source>Nat. Rev. Dis. Primers.</source><year>2016</year><volume>2</volume><fpage>16047</fpage><pub-id pub-id-type="doi">10.1038/nrdp.2016.47</pub-id><pub-id pub-id-type="pmid">27383445</pub-id></element-citation></ref><ref id="B4-nutrients-17-02743"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jonsson</surname><given-names>R.</given-names></name></person-group><article-title>Disease mechanisms in Sj&#246;gren&#8217;s syndrome: What do we know?</article-title><source>Scand. J. Immunol.</source><year>2022</year><volume>95</volume><fpage>e13145</fpage><pub-id pub-id-type="doi">10.1111/sji.13145</pub-id><pub-id pub-id-type="pmid">35073430</pub-id></element-citation></ref><ref id="B5-nutrients-17-02743"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beydon</surname><given-names>M.</given-names></name><name name-style="western"><surname>McCoy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sumida</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mariette</surname><given-names>X.</given-names></name><name name-style="western"><surname>Seror</surname><given-names>R.</given-names></name></person-group><article-title>Epidemiology of Sj&#246;gren syndrome</article-title><source>Nat. Rev. Rheumatol.</source><year>2024</year><volume>20</volume><fpage>158</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1038/s41584-023-01057-6</pub-id><pub-id pub-id-type="pmid">38110617</pub-id></element-citation></ref><ref id="B6-nutrients-17-02743"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nocturne</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mariette</surname><given-names>X.</given-names></name></person-group><article-title>Sj&#246;gren Syndrome-associated lymphomas: An update on pathogenesis and management</article-title><source>Br. J. Haematol.</source><year>2015</year><volume>168</volume><fpage>317</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1111/bjh.13192</pub-id><pub-id pub-id-type="pmid">25316606</pub-id></element-citation></ref><ref id="B7-nutrients-17-02743"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramos-Casals</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brito-Zer&#243;n</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bombardieri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bootsma</surname><given-names>H.</given-names></name><name name-style="western"><surname>De Vita</surname><given-names>S.</given-names></name><name name-style="western"><surname>D&#246;rner</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Gottenberg</surname><given-names>J.-E.</given-names></name><name name-style="western"><surname>Hernandez-Molina</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kocher</surname><given-names>A.</given-names></name><etal/></person-group><article-title>EULAR recommendations for the management of Sj&#246;gren&#8217;s syndrome with topical and systemic therapies</article-title><source>Ann. Rheum. Dis.</source><year>2020</year><volume>79</volume><fpage>3</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2019-216114</pub-id><pub-id pub-id-type="pmid">31672775</pub-id></element-citation></ref><ref id="B8-nutrients-17-02743"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fox</surname><given-names>R.I.</given-names></name><name name-style="western"><surname>Fox</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Gottenberg</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>D&#246;rner</surname><given-names>T.</given-names></name></person-group><article-title>Treatment of Sj&#246;gren&#8217;s syndrome: Current therapy and future directions</article-title><source>Rheumatology</source><year>2021</year><volume>60</volume><fpage>2066</fpage><lpage>2074</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/kez142</pub-id><pub-id pub-id-type="pmid">31034046</pub-id></element-citation></ref><ref id="B9-nutrients-17-02743"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Enger</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Palm</surname><given-names>&#216;.</given-names></name><name name-style="western"><surname>Garen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sandvik</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>J.L.</given-names></name></person-group><article-title>Oral distress in primary Sj&#246;gren&#8217;s syndrome: Implications for health-related quality of life</article-title><source>Eur. J. Oral Sci.</source><year>2011</year><volume>119</volume><fpage>474</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0722.2011.00891.x</pub-id><pub-id pub-id-type="pmid">22112034</pub-id></element-citation></ref><ref id="B10-nutrients-17-02743"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sung</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sep&#250;lveda</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Molina</surname><given-names>C.</given-names></name></person-group><article-title>Oral manifestations and their treatment in Sj&#246;gren&#8217;s syndrome</article-title><source>Oral Dis.</source><year>2014</year><volume>20</volume><fpage>153</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1111/odi.12105</pub-id><pub-id pub-id-type="pmid">23557026</pub-id></element-citation></ref><ref id="B11-nutrients-17-02743"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyamoto</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Valim</surname><given-names>V.</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>B.A.</given-names></name></person-group><article-title>Health-related quality of life and costs in Sj&#246;gren&#8217;s syndrome</article-title><source>Rheumatology</source><year>2021</year><volume>60</volume><fpage>2588</fpage><lpage>2601</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/key370</pub-id><pub-id pub-id-type="pmid">30770918</pub-id></element-citation></ref><ref id="B12-nutrients-17-02743"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rusthen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Young</surname><given-names>A.</given-names></name><name name-style="western"><surname>Herlofson</surname><given-names>B.B.</given-names></name><name name-style="western"><surname>Aqrawi</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Rykke</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hove</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Palm</surname><given-names>&#216;.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>P.B.</given-names></name></person-group><article-title>Oral disorders, saliva secretion, and oral health-related quality of life in patients with primary Sj&#246;gren&#8217;s syndrome</article-title><source>Eur. J. Oral Sci.</source><year>2017</year><volume>125</volume><fpage>65</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1111/eos.12358</pub-id><pub-id pub-id-type="pmid">28643390</pub-id></element-citation></ref><ref id="B13-nutrients-17-02743"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nesvold</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Hove</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Young</surname><given-names>A.</given-names></name><name name-style="western"><surname>Palm</surname><given-names>&#216;.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Carlsen</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Iversen</surname><given-names>P.O.</given-names></name></person-group><article-title>Dietary intake, body composition, and oral health parameters among female patients with primary Sj&#246;gren&#8217;s syndrome</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><elocation-id>866</elocation-id><pub-id pub-id-type="doi">10.3390/nu10070866</pub-id><pub-id pub-id-type="pmid">29973575</pub-id><pub-id pub-id-type="pmcid">PMC6073564</pub-id></element-citation></ref><ref id="B14-nutrients-17-02743"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandes</surname><given-names>G.</given-names></name><name name-style="western"><surname>Jolly</surname><given-names>C.A.</given-names></name></person-group><article-title>Nutrition and autoimmune disease</article-title><source>Nutr. Rev.</source><year>1998</year><volume>56</volume><issue-part>Pt 2</issue-part><fpage>S161</fpage><lpage>S169</lpage><pub-id pub-id-type="doi">10.1111/j.1753-4887.1998.tb01635.x</pub-id><pub-id pub-id-type="pmid">9481139</pub-id></element-citation></ref><ref id="B15-nutrients-17-02743"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vieira</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Pagovich</surname><given-names>O.E.</given-names></name><name name-style="western"><surname>Kriegel</surname><given-names>M.A.</given-names></name></person-group><article-title>Diet, microbiota and autoimmune diseases</article-title><source>Lupus</source><year>2014</year><volume>23</volume><fpage>518</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1177/0961203313501401</pub-id><pub-id pub-id-type="pmid">24763536</pub-id><pub-id pub-id-type="pmcid">PMC4009622</pub-id></element-citation></ref><ref id="B16-nutrients-17-02743"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cermak</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Papas</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Dana</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>D.A.</given-names></name></person-group><article-title>Nutrient intake in women with primary and secondary Sj&#246;gren&#8217;s syndrome</article-title><source>Eur. J. Clin. Nutr.</source><year>2003</year><volume>57</volume><fpage>328</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1601543</pub-id><pub-id pub-id-type="pmid">12571668</pub-id></element-citation></ref><ref id="B17-nutrients-17-02743"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szodoray</surname><given-names>P.</given-names></name><name name-style="western"><surname>Horvath</surname><given-names>I.F.</given-names></name><name name-style="western"><surname>Papp</surname><given-names>G.</given-names></name><name name-style="western"><surname>Barath</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gyimesi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Csathy</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kappelmayer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sipka</surname><given-names>S.</given-names></name><name name-style="western"><surname>Duttaroy</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Nakken</surname><given-names>B.</given-names></name><etal/></person-group><article-title>The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren&#8217;s syndrome</article-title><source>Rheumatology</source><year>2010</year><volume>49</volume><fpage>211</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/kep374</pub-id><pub-id pub-id-type="pmid">19946023</pub-id></element-citation></ref><ref id="B18-nutrients-17-02743"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>X.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>K.</given-names></name><etal/></person-group><article-title>High-fat diet-induced functional and pathologic changes in lacrimal gland</article-title><source>Am. J. Pathol.</source><year>2020</year><volume>190</volume><fpage>2387</fpage><lpage>2402</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2020.09.002</pub-id><pub-id pub-id-type="pmid">32919976</pub-id></element-citation></ref><ref id="B19-nutrients-17-02743"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Machowicz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>I.</given-names></name><name name-style="western"><surname>de Pablo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Rauz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Richards</surname><given-names>A.</given-names></name><name name-style="western"><surname>Higham</surname><given-names>J.</given-names></name><name name-style="western"><surname>Poveda-Gallego</surname><given-names>A.</given-names></name><name name-style="western"><surname>Imamura</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bowman</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Barone</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Mediterranean diet and risk of Sj&#246;gren&#8217;s syndrome</article-title><source>Clin Exp Rheumatol.</source><year>2020</year><volume>38</volume><issue>(Suppl. 126)</issue><fpage>216</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">33095150</pub-id></element-citation></ref><ref id="B20-nutrients-17-02743"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>G.</given-names></name></person-group><article-title>High-fat diet-induced intestinal dysbiosis is associated with the exacerbation of Sjogren&#8217;s syndrome</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><elocation-id>916089</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2022.916089</pub-id><pub-id pub-id-type="pmid">35935193</pub-id><pub-id pub-id-type="pmcid">PMC9354669</pub-id></element-citation></ref><ref id="B21-nutrients-17-02743"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haddaway</surname><given-names>N.R.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Coughlin</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kirk</surname><given-names>S.</given-names></name></person-group><article-title>The role of google scholar in evidence reviews and its applicability to grey literature searching</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0138237</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0138237</pub-id><pub-id pub-id-type="pmid">26379270</pub-id><pub-id pub-id-type="pmcid">PMC4574933</pub-id></element-citation></ref><ref id="B22-nutrients-17-02743"><label>22.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Moola</surname><given-names>S.</given-names></name><name name-style="western"><surname>Munn</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Tufunaru</surname><given-names>C.</given-names></name><name name-style="western"><surname>Aromataris</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sears</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sfetc</surname><given-names>R.</given-names></name><name name-style="western"><surname>Currie</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lisy</surname><given-names>K.</given-names></name><name name-style="western"><surname>Qureshi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mattis</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Chapter 7: Systematic reviews of etiology and risk</article-title><source>JBI Manual for Evidence Synthesis</source><person-group person-group-type="editor"><name name-style="western"><surname>Aromataris</surname><given-names>E.</given-names></name><name name-style="western"><surname>Munn</surname><given-names>Z.</given-names></name></person-group><publisher-name>JBI</publisher-name><publisher-loc>Adelaide, Australia</publisher-loc><year>2020</year><pub-id pub-id-type="doi">10.46658/JBIMES-24-06</pub-id></element-citation></ref><ref id="B23-nutrients-17-02743"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barker</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Stone</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Sears</surname><given-names>K.</given-names></name><name name-style="western"><surname>Klugar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tufanaru</surname><given-names>C.</given-names></name><name name-style="western"><surname>Leonardi-Bee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Aromataris</surname><given-names>E.</given-names></name><name name-style="western"><surname>Munn</surname><given-names>Z.</given-names></name></person-group><article-title>The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials</article-title><source>JBI Evid. Synth.</source><year>2023</year><volume>21</volume><fpage>494</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.11124/JBIES-22-00430</pub-id><pub-id pub-id-type="pmid">36727247</pub-id></element-citation></ref><ref id="B24-nutrients-17-02743"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hooijmans</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Rovers</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>de Vries</surname><given-names>R.B.M.</given-names></name><name name-style="western"><surname>Leenaars</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ritskes-Hoitinga</surname><given-names>M.</given-names></name><name name-style="western"><surname>Langendam</surname><given-names>M.W.</given-names></name></person-group><article-title>SYRCLE&#8217;s risk of bias tool for animal studies</article-title><source>BMC Med. Res. Methodol.</source><year>2014</year><volume>14</volume><elocation-id>43</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2288-14-43</pub-id><pub-id pub-id-type="pmid">24667063</pub-id><pub-id pub-id-type="pmcid">PMC4230647</pub-id></element-citation></ref><ref id="B25-nutrients-17-02743"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Page</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Bossuyt</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Boutron</surname><given-names>I.</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Mulrow</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Shamseer</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tetzlaff</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Akl</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>S.E.</given-names></name><etal/></person-group><article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>71</fpage><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id><pub-id pub-id-type="pmid">33782057</pub-id></element-citation></ref><ref id="B26-nutrients-17-02743"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swanson</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Levy</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Morrow</surname><given-names>W.J.</given-names></name></person-group><article-title>Effect of low dietary lipid on the development of Sj&#246;gren&#8217;s syndrome and haematological abnormalities in (NZB x NZW)F1 mice</article-title><source>Ann. Rheum. Dis.</source><year>1989</year><volume>48</volume><fpage>765</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1136/ard.48.9.765</pub-id><pub-id pub-id-type="pmid">2802799</pub-id><pub-id pub-id-type="pmcid">PMC1003871</pub-id></element-citation></ref><ref id="B27-nutrients-17-02743"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chandrasekar</surname><given-names>B.</given-names></name><name name-style="western"><surname>McGuff</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Aufdermorte</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Troyer</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Talal</surname><given-names>N.</given-names></name><name name-style="western"><surname>Fernandes</surname><given-names>G.</given-names></name></person-group><article-title>Effects of calorie restriction on transforming growth factor beta 1 and proinflammatory cytokines in murine Sjogren&#8217;s syndrome</article-title><source>Clin. Immunol. Immunopathol.</source><year>1995</year><volume>76</volume><issue-part>Pt 1</issue-part><fpage>291</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1006/clin.1995.1128</pub-id><pub-id pub-id-type="pmid">7554451</pub-id></element-citation></ref><ref id="B28-nutrients-17-02743"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kishimoto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ushikoshi-Nakayama</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hasaka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ryo</surname><given-names>K.</given-names></name><name name-style="western"><surname>Muramatsu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ide</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mishima</surname><given-names>K.</given-names></name><name name-style="western"><surname>Saito</surname><given-names>I.</given-names></name></person-group><article-title>Resveratrol improves salivary dysfunction in a non-obese diabetic (NOD) mouse model of Sj&#246;gren&#8217;s syndrome</article-title><source>J. Clin. Biochem. Nutr.</source><year>2016</year><volume>59</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.3164/jcbn.16-31</pub-id><pub-id pub-id-type="pmid">27698537</pub-id><pub-id pub-id-type="pmcid">PMC5018577</pub-id></element-citation></ref><ref id="B29-nutrients-17-02743"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>Triptolide reduces salivary gland damage in a non-obese diabetic mice model of Sj&#246;gren&#8217;s syndrome via JAK/STAT and NF-&#954;B signaling pathways</article-title><source>J. Clin. Biochem. Nutr.</source><year>2021</year><volume>68</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.3164/jcbn.20-15</pub-id><pub-id pub-id-type="pmid">33879964</pub-id><pub-id pub-id-type="pmcid">PMC8046007</pub-id></element-citation></ref><ref id="B30-nutrients-17-02743"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haupt-Jorgensen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Groule</surname><given-names>V.</given-names></name><name name-style="western"><surname>Reibel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Buschard</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>A.M.L.</given-names></name></person-group><article-title>Gluten-free diet modulates inflammation in salivary glands and pancreatic islets</article-title><source>Oral Dis.</source><year>2022</year><volume>28</volume><fpage>639</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1111/odi.13775</pub-id><pub-id pub-id-type="pmid">33432638</pub-id></element-citation></ref><ref id="B31-nutrients-17-02743"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Duan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>He</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Lycium barbarum polysaccharide ameliorates Sj&#246;gren&#8217;s syndrome in a murine model</article-title><source>Mol. Nutr. Food Res.</source><year>2021</year><volume>65</volume><fpage>e2001118</fpage><pub-id pub-id-type="doi">10.1002/mnfr.202001118</pub-id><pub-id pub-id-type="pmid">33825332</pub-id></element-citation></ref><ref id="B32-nutrients-17-02743"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name><name name-style="western"><surname>Onodera</surname><given-names>S.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Alnujaydi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name></person-group><article-title>Alternate-day fasting ameliorates newly established Sj&#246;gren&#8217;s syndrome-like sialadenitis in non-obese diabetic mice</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>13791</elocation-id><pub-id pub-id-type="doi">10.3390/ijms232213791</pub-id><pub-id pub-id-type="pmid">36430269</pub-id><pub-id pub-id-type="pmcid">PMC9695328</pub-id></element-citation></ref><ref id="B33-nutrients-17-02743"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name><name name-style="western"><surname>Onodera</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name></person-group><article-title>The impact of alternate-day fasting on the salivary gland stem cell compartments in non-obese diabetic mice with newly established Sj&#246;gren&#8217;s syndrome</article-title><source>Biochim. Biophys. Acta Mol. Cell Res.</source><year>2024</year><volume>1871</volume><elocation-id>119817</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbamcr.2024.119817</pub-id><pub-id pub-id-type="pmid">39159683</pub-id><pub-id pub-id-type="pmcid">PMC11368138</pub-id></element-citation></ref><ref id="B34-nutrients-17-02743"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raffle</surname><given-names>R.B.</given-names></name></person-group><article-title>Sj&#246;gren&#8217;s disease associated with a nutritional deficiency syndrome</article-title><source>Br. Med. J.</source><year>1950</year><volume>1</volume><fpage>1470</fpage><lpage>1471</lpage><pub-id pub-id-type="doi">10.1136/bmj.1.4668.1470</pub-id><pub-id pub-id-type="pmid">15426778</pub-id><pub-id pub-id-type="pmcid">PMC2037937</pub-id></element-citation></ref><ref id="B35-nutrients-17-02743"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maclaurin</surname><given-names>B.P.</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kilpatrick</surname><given-names>J.A.</given-names></name></person-group><article-title>Coeliac disease associated with auto-immune thyroiditis, Sjogren&#8217;s syndrome, and a lymphocytotoxic serum factor</article-title><source>Aust. N. Z. J. Med.</source><year>1972</year><volume>2</volume><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1111/j.1445-5994.1972.tb03946.x</pub-id><pub-id pub-id-type="pmid">4512376</pub-id></element-citation></ref><ref id="B36-nutrients-17-02743"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horrobin</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>A.</given-names></name></person-group><article-title>Sjogren&#8217;s syndrome and the sicca syndrome: The role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C</article-title><source>Med. Hypotheses</source><year>1980</year><volume>6</volume><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/0306-9877(80)90120-6</pub-id><pub-id pub-id-type="pmid">7432243</pub-id></element-citation></ref><ref id="B37-nutrients-17-02743"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKendry</surname><given-names>R.J.</given-names></name></person-group><article-title>Treatment of Sjogren&#8217;s syndrome with essential fatty acids, pyridoxine and vitamin C</article-title><source>Prostaglandins Leukot. Med.</source><year>1982</year><volume>8</volume><fpage>403</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/0262-1746(82)90064-6</pub-id><pub-id pub-id-type="pmid">6955809</pub-id></element-citation></ref><ref id="B38-nutrients-17-02743"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pedersen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gerner</surname><given-names>N.</given-names></name><name name-style="western"><surname>Palmvang</surname><given-names>I.</given-names></name><name name-style="western"><surname>H&#248;ier-Madsen</surname><given-names>M.</given-names></name></person-group><article-title>LongoVital in the treatment of Sj&#246;gren&#8217;s syndrome</article-title><source>Clin. Exp. Rheumatol.</source><year>1999</year><volume>17</volume><fpage>533</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">10544835</pub-id></element-citation></ref><ref id="B39-nutrients-17-02743"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vitali</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bombardieri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moutsopoulos</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Balestrieri</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bencivelli</surname><given-names>W.</given-names></name><name name-style="western"><surname>Bernstein</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Bjerrum</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Braga</surname><given-names>S.</given-names></name><name name-style="western"><surname>Coll</surname><given-names>J.</given-names></name><name name-style="western"><surname>de Vita</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Preliminary criteria for the classification of Sj&#246;gren&#8217;s syndrome. Results of a prospective concerted action supported by the European Community</article-title><source>Arthritis Rheum.</source><year>1993</year><volume>36</volume><fpage>340</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1002/art.1780360309</pub-id><pub-id pub-id-type="pmid">8452579</pub-id></element-citation></ref><ref id="B40-nutrients-17-02743"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Haga</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Haugen</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Kahrs</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Haugen</surname><given-names>M.</given-names></name></person-group><article-title>The effect of a liquid diet on salivary flow in primary Sj&#246;gren&#8217;s syndrome</article-title><source>Scand. J. Rheumatol.</source><year>2008</year><volume>37</volume><fpage>236</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1080/03009740701747145</pub-id><pub-id pub-id-type="pmid">18465463</pub-id></element-citation></ref><ref id="B41-nutrients-17-02743"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vitali</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bombardieri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jonsson</surname><given-names>R.</given-names></name><name name-style="western"><surname>Moutsopoulos</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Carsons</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>T.E.</given-names></name><name name-style="western"><surname>Fox</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Fox</surname><given-names>R.I.</given-names></name><name name-style="western"><surname>Kassan</surname><given-names>S.S.</given-names></name><etal/></person-group><article-title>Classification criteria for Sj&#246;gren&#8217;s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group</article-title><source>Ann. Rheum. Dis.</source><year>2002</year><volume>61</volume><fpage>554</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1136/ard.61.6.554</pub-id><pub-id pub-id-type="pmid">12006334</pub-id><pub-id pub-id-type="pmcid">PMC1754137</pub-id></element-citation></ref><ref id="B42-nutrients-17-02743"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Stark</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Gilbard</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Papas</surname><given-names>A.S.</given-names></name></person-group><article-title>Effect of omega-3 and vitamin E supplementation on dry mouth in patients with Sj&#246;gren&#8217;s syndrome</article-title><source>Spec. Care Dentist.</source><year>2010</year><volume>30</volume><fpage>225</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1111/j.1754-4505.2010.00158.x</pub-id><pub-id pub-id-type="pmid">21044101</pub-id></element-citation></ref><ref id="B43-nutrients-17-02743"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>C.Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>I.H.</given-names></name><name name-style="western"><surname>Shiang</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>M.K.</given-names></name></person-group><article-title>Hypokalemic paralysis as a presenting manifestation of primary Sj&#246;gren&#8217;s syndrome accompanied by vitamin D deficiency</article-title><source>Intern. Med.</source><year>2013</year><volume>52</volume><fpage>2351</fpage><lpage>2353</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.52.0899</pub-id><pub-id pub-id-type="pmid">24126399</pub-id></element-citation></ref><ref id="B44-nutrients-17-02743"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldner</surname><given-names>B.</given-names></name><name name-style="western"><surname>Staffier</surname><given-names>K.L.</given-names></name></person-group><article-title>Case series: Raw, whole, plant-based nutrition protocol rapidly reverses symptoms in three women with systemic lupus erythematosus and Sj&#246;gren&#8217;s syndrome</article-title><source>Front. Nutr.</source><year>2024</year><volume>11</volume><elocation-id>1208074</elocation-id><pub-id pub-id-type="doi">10.3389/fnut.2024.1208074</pub-id><pub-id pub-id-type="pmid">38505266</pub-id><pub-id pub-id-type="pmcid">PMC10949923</pub-id></element-citation></ref><ref id="B45-nutrients-17-02743"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Rawi</surname><given-names>Z.S.</given-names></name><name name-style="western"><surname>Jalal</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Hameed</surname><given-names>I.H.</given-names></name></person-group><article-title>A randomized double-blind placebo-controlled clinical trial of fish oil (omega-3) in Sjogren&#8217;s syndrome patients in Erbil-Iraq</article-title><source>Mediterr. J. Rheumatol.</source><year>2024</year><volume>36</volume><fpage>92</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.31138/mjr.090224.rdb</pub-id><pub-id pub-id-type="pmid">40557177</pub-id><pub-id pub-id-type="pmcid">PMC12183441</pub-id></element-citation></ref><ref id="B46-nutrients-17-02743"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rhodus</surname><given-names>N.L.</given-names></name></person-group><article-title>Qualitative nutritional intake analysis of older adults with Sjogren&#8217;s syndrome</article-title><source>Gerodontology</source><year>1988</year><volume>7</volume><fpage>61</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1111/j.1741-2358.1988.tb00306.x</pub-id><pub-id pub-id-type="pmid">3273284</pub-id></element-citation></ref><ref id="B47-nutrients-17-02743"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henderson</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Panush</surname><given-names>R.S.</given-names></name></person-group><article-title>Diets, dietary supplements, and nutritional therapies in rheumatic diseases</article-title><source>Rheum. Dis. Clin. N. Am.</source><year>1999</year><volume>25</volume><fpage>937</fpage><lpage>968</lpage><pub-id pub-id-type="doi">10.1016/S0889-857X(05)70112-5</pub-id><pub-id pub-id-type="pmid">10573768</pub-id></element-citation></ref><ref id="B48-nutrients-17-02743"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Semerano</surname><given-names>L.</given-names></name><name name-style="western"><surname>Julia</surname><given-names>C.</given-names></name><name name-style="western"><surname>Aitisha</surname><given-names>O.</given-names></name><name name-style="western"><surname>Boissier</surname><given-names>M.C.</given-names></name></person-group><article-title>Nutrition and chronic inflammatory rheumatic disease</article-title><source>Jt. Bone Spine</source><year>2017</year><volume>84</volume><fpage>547</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1016/j.jbspin.2016.10.003</pub-id><pub-id pub-id-type="pmid">27914804</pub-id></element-citation></ref><ref id="B49-nutrients-17-02743"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nobs</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Zmora</surname><given-names>N.</given-names></name><name name-style="western"><surname>Elinav</surname><given-names>E.</given-names></name></person-group><article-title>Nutrition regulates innate immunity in health and disease</article-title><source>Annu. Rev. Nutr.</source><year>2020</year><volume>40</volume><fpage>189</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1146/annurev-nutr-120919-094440</pub-id><pub-id pub-id-type="pmid">32520640</pub-id></element-citation></ref><ref id="B50-nutrients-17-02743"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwager</surname><given-names>J.</given-names></name><name name-style="western"><surname>Seifert</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bompard</surname><given-names>A.</given-names></name><name name-style="western"><surname>Raederstorff</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bendik</surname><given-names>I.</given-names></name></person-group><article-title>Resveratrol, EGCG and vitamins modulate activated T lymphocytes</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>5600</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26185600</pub-id><pub-id pub-id-type="pmid">34577071</pub-id><pub-id pub-id-type="pmcid">PMC8470394</pub-id></element-citation></ref><ref id="B51-nutrients-17-02743"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Q.</given-names></name></person-group><article-title>Triptolide and its expanding multiple pharmacological functions</article-title><source>Int. Immunopharmacol.</source><year>2011</year><volume>11</volume><fpage>377</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2011.01.012</pub-id><pub-id pub-id-type="pmid">21255694</pub-id></element-citation></ref><ref id="B52-nutrients-17-02743"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moudgil</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Venkatesha</surname><given-names>S.H.</given-names></name></person-group><article-title>The anti-inflammatory and immunomodulatory activities of natural products to control autoimmune inflammation</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>24</volume><elocation-id>95</elocation-id><pub-id pub-id-type="doi">10.3390/ijms24010095</pub-id><pub-id pub-id-type="pmid">36613560</pub-id><pub-id pub-id-type="pmcid">PMC9820125</pub-id></element-citation></ref><ref id="B53-nutrients-17-02743"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chien</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Horng</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.S.</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F.</given-names></name></person-group><article-title>Effects of Lycium barbarum (goji berry) on dry eye disease in rats</article-title><source>Mol. Med. Rep.</source><year>2018</year><volume>17</volume><fpage>809</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.3892/mmr.2017.7947</pub-id><pub-id pub-id-type="pmid">29115477</pub-id><pub-id pub-id-type="pmcid">PMC5780158</pub-id></element-citation></ref><ref id="B54-nutrients-17-02743"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Han</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Lipid metabolism: An emerging player in Sj&#246;gren&#8217;s syndrome</article-title><source>Clin. Rev. Allergy Immunol.</source><year>2025</year><volume>68</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1007/s12016-025-09023-8</pub-id><pub-id pub-id-type="pmid">39934534</pub-id><pub-id pub-id-type="pmcid">PMC11813826</pub-id></element-citation></ref><ref id="B55-nutrients-17-02743"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mora</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Iwata</surname><given-names>M.</given-names></name><name name-style="western"><surname>von Andrian</surname><given-names>U.H.</given-names></name></person-group><article-title>Vitamin effects on the immune system: Vitamins A and D take centre stage</article-title><source>Nat. Rev. Immunol.</source><year>2008</year><volume>8</volume><fpage>685</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1038/nri2378</pub-id><pub-id pub-id-type="pmid">19172691</pub-id><pub-id pub-id-type="pmcid">PMC2906676</pub-id></element-citation></ref><ref id="B56-nutrients-17-02743"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radi&#263;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kolak</surname><given-names>E.</given-names></name><name name-style="western"><surname>&#272;oga&#353;</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gelemanovi&#263;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nenadi&#263;</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Vu&#269;kovi&#263;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Radi&#263;</surname><given-names>J.</given-names></name></person-group><article-title>Vitamin D and Sj&#246;gren&#8217;s disease: Revealing the connections-a systematic review and meta-analysis</article-title><source>Nutrients</source><year>2023</year><volume>15</volume><elocation-id>497</elocation-id><pub-id pub-id-type="doi">10.3390/nu15030497</pub-id><pub-id pub-id-type="pmid">36771203</pub-id><pub-id pub-id-type="pmcid">PMC9920259</pub-id></element-citation></ref><ref id="B57-nutrients-17-02743"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isola</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gammeri</surname><given-names>L.</given-names></name><name name-style="western"><surname>Furci</surname><given-names>F.</given-names></name><name name-style="western"><surname>Gangemi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pioggia</surname><given-names>G.</given-names></name><name name-style="western"><surname>Allegra</surname><given-names>A.</given-names></name></person-group><article-title>Vitamin C supplementation in the treatment of autoimmune and onco-hematological diseases: From prophylaxis to adjuvant therapy</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>7284</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25137284</pub-id><pub-id pub-id-type="pmid">39000393</pub-id><pub-id pub-id-type="pmcid">PMC11241675</pub-id></element-citation></ref><ref id="B58-nutrients-17-02743"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simopoulos</surname><given-names>A.P.</given-names></name></person-group><article-title>Omega-3 fatty acids in inflammation and autoimmune diseases</article-title><source>J. Am. Coll. Nutr.</source><year>2002</year><volume>21</volume><fpage>495</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1080/07315724.2002.10719248</pub-id><pub-id pub-id-type="pmid">12480795</pub-id></element-citation></ref><ref id="B59-nutrients-17-02743"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poggioli</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hirani</surname><given-names>K.</given-names></name><name name-style="western"><surname>Jogani</surname><given-names>V.G.</given-names></name><name name-style="western"><surname>Ricordi</surname><given-names>C.</given-names></name></person-group><article-title>Modulation of inflammation and immunity by omega-3 fatty acids: A possible role for prevention and to halt disease progression in autoimmune, viral, and age-related disorders</article-title><source>Eur. Rev. Med. Pharmacol. Sci.</source><year>2023</year><volume>27</volume><fpage>7380</fpage><lpage>7400</lpage><pub-id pub-id-type="doi">10.26355/eurrev_202308_33310</pub-id><pub-id pub-id-type="pmid">37606147</pub-id></element-citation></ref><ref id="B60-nutrients-17-02743"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castrej&#243;n-Morales</surname><given-names>C.Y.</given-names></name><name name-style="western"><surname>Granados-Portillo</surname><given-names>O.</given-names></name><name name-style="western"><surname>Cruz-Bautista</surname><given-names>I.</given-names></name><name name-style="western"><surname>Ruiz-Quintero</surname><given-names>N.</given-names></name><name name-style="western"><surname>Manjarrez</surname><given-names>I.</given-names></name><name name-style="western"><surname>Lima</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hern&#225;ndez-Ram&#237;rez</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Astudillo-Angel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Llorente</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hern&#225;ndez-Molina</surname><given-names>G.</given-names></name></person-group><article-title>Omega-3 and omega-6 fatty acids in primary Sj&#246;gren&#8217;s syndrome: Clinical meaning and association with inflammation</article-title><source>Clin. Exp. Rheumatol.</source><year>2020</year><volume>38</volume><issue>(Suppl. 126)</issue><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">32896265</pub-id></element-citation></ref><ref id="B61-nutrients-17-02743"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>da Nave</surname><given-names>C.B.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>P.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>M.L.</given-names></name></person-group><article-title>The effect of polyunsaturated fatty acid (PUFA) supplementation on clinical manifestations and inflammatory parameters in individuals with Sj&#246;gren&#8217;s syndrome: A literature review of randomized controlled clinical trials</article-title><source>Nutrients</source><year>2024</year><volume>16</volume><elocation-id>3786</elocation-id><pub-id pub-id-type="doi">10.3390/nu16213786</pub-id><pub-id pub-id-type="pmid">39519619</pub-id><pub-id pub-id-type="pmcid">PMC11547869</pub-id></element-citation></ref><ref id="B62-nutrients-17-02743"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maarse</surname><given-names>F.</given-names></name><name name-style="western"><surname>Jager</surname><given-names>D.H.J.</given-names></name><name name-style="western"><surname>Alterch</surname><given-names>S.</given-names></name><name name-style="western"><surname>Korfage</surname><given-names>A.</given-names></name><name name-style="western"><surname>Forouzanfar</surname><given-names>T.</given-names></name><name name-style="western"><surname>Vissink</surname><given-names>A.</given-names></name><name name-style="western"><surname>Brand</surname><given-names>H.S.</given-names></name></person-group><article-title>Sj&#246;gren&#8217;s syndrome is not a risk factor for periodontal disease: A systematic review</article-title><source>Clin. Exp. Rheumatol.</source><year>2019</year><volume>37</volume><issue>(Suppl. 118)</issue><fpage>225</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">31464667</pub-id></element-citation></ref><ref id="B63-nutrients-17-02743"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lerner</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shoenfeld</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Matthias</surname><given-names>T.</given-names></name></person-group><article-title>Adverse effects of gluten ingestion and advantages of gluten withdrawal in nonceliac autoimmune disease</article-title><source>Nutr. Rev.</source><year>2017</year><volume>75</volume><fpage>1046</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1093/nutrit/nux054</pub-id><pub-id pub-id-type="pmid">29202198</pub-id></element-citation></ref><ref id="B64-nutrients-17-02743"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruzzese</surname><given-names>V.</given-names></name><name name-style="western"><surname>Scolieri</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pepe</surname><given-names>J.</given-names></name></person-group><article-title>Efficacy of gluten-free diet in patients with rheumatoid arthritis</article-title><source>Reumatismo</source><year>2021</year><volume>72</volume><fpage>213</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.4081/reumatismo.2020.1296</pub-id><pub-id pub-id-type="pmid">33677948</pub-id></element-citation></ref><ref id="B65-nutrients-17-02743"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lerner</surname><given-names>A.</given-names></name><name name-style="western"><surname>de Carvalho</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Kotrova</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shoenfeld</surname><given-names>Y.</given-names></name></person-group><article-title>Gluten-free diet can ameliorate the symptoms of non-celiac autoimmune diseases</article-title><source>Nutr. Rev.</source><year>2022</year><volume>80</volume><fpage>525</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1093/nutrit/nuab039</pub-id><pub-id pub-id-type="pmid">34338776</pub-id></element-citation></ref><ref id="B66-nutrients-17-02743"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clemente-Su&#225;rez</surname><given-names>V.J.</given-names></name><name name-style="western"><surname>Beltr&#225;n-Velasco</surname><given-names>A.I.</given-names></name><name name-style="western"><surname>Redondo-Fl&#243;rez</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mart&#237;n-Rodr&#237;guez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tornero-Aguilera</surname><given-names>J.F.</given-names></name></person-group><article-title>Global impacts of Western diet and its effects on metabolism and health: A narrative review</article-title><source>Nutrients</source><year>2023</year><volume>15</volume><elocation-id>2749</elocation-id><pub-id pub-id-type="doi">10.3390/nu15122749</pub-id><pub-id pub-id-type="pmid">37375654</pub-id><pub-id pub-id-type="pmcid">PMC10302286</pub-id></element-citation></ref><ref id="B67-nutrients-17-02743"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manzel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Muller</surname><given-names>D.N.</given-names></name><name name-style="western"><surname>Hafler</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Erdman</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Linker</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Kleinewietfeld</surname><given-names>M.</given-names></name></person-group><article-title>Role of &#8220;Western diet&#8221; in inflammatory autoimmune diseases</article-title><source>Curr. Allergy Asthma Rep.</source><year>2014</year><volume>14</volume><fpage>404</fpage><pub-id pub-id-type="doi">10.1007/s11882-013-0404-6</pub-id><pub-id pub-id-type="pmid">24338487</pub-id><pub-id pub-id-type="pmcid">PMC4034518</pub-id></element-citation></ref><ref id="B68-nutrients-17-02743"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malesza</surname><given-names>I.J.</given-names></name><name name-style="western"><surname>Malesza</surname><given-names>M.</given-names></name><name name-style="western"><surname>Walkowiak</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mussin</surname><given-names>N.</given-names></name><name name-style="western"><surname>Walkowiak</surname><given-names>D.</given-names></name><name name-style="western"><surname>Aringazina</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bartkowiak-Wieczorek</surname><given-names>J.</given-names></name><name name-style="western"><surname>M&#261;dry</surname><given-names>E.</given-names></name></person-group><article-title>High-fat, Western-style diet, systemic inflammation, and gut microbiota: A narrative review</article-title><source>Cells</source><year>2021</year><volume>10</volume><elocation-id>3164</elocation-id><pub-id pub-id-type="doi">10.3390/cells10113164</pub-id><pub-id pub-id-type="pmid">34831387</pub-id><pub-id pub-id-type="pmcid">PMC8619527</pub-id></element-citation></ref><ref id="B69-nutrients-17-02743"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Fei</surname><given-names>Y.</given-names></name></person-group><article-title>A glimpse into the microbiome of Sj&#246;gren&#8217;s syndrome</article-title><source>Front. Immunol.</source><year>2022</year><volume>13</volume><elocation-id>918619</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.918619</pub-id><pub-id pub-id-type="pmid">35911741</pub-id><pub-id pub-id-type="pmcid">PMC9329934</pub-id></element-citation></ref><ref id="B70-nutrients-17-02743"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Carvalho</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Lerner</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gon&#231;alves</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Shoenfeld</surname><given-names>Y.</given-names></name></person-group><article-title>Sj&#246;gren syndrome associated with protein-losing enteropathy: Case-based review</article-title><source>Clin. Rheumatol.</source><year>2021</year><volume>40</volume><fpage>2491</fpage><lpage>2497</lpage><pub-id pub-id-type="doi">10.1007/s10067-020-05487-5</pub-id><pub-id pub-id-type="pmid">33145631</pub-id></element-citation></ref><ref id="B71-nutrients-17-02743"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medina</surname><given-names>G.</given-names></name><name name-style="western"><surname>Vera-Lastra</surname><given-names>O.</given-names></name><name name-style="western"><surname>Peralta-Amaro</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Jim&#233;nez-Arellano</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Saavedra</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Cruz-Dom&#237;nguez</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Jara</surname><given-names>L.J.</given-names></name></person-group><article-title>Metabolic syndrome, autoimmunity and rheumatic diseases</article-title><source>Pharmacol. Res.</source><year>2018</year><volume>133</volume><fpage>277</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2018.01.009</pub-id><pub-id pub-id-type="pmid">29382608</pub-id></element-citation></ref><ref id="B72-nutrients-17-02743"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Augusto</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Bonfa</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>R.M.R.</given-names></name><name name-style="western"><surname>Bueno</surname><given-names>C.</given-names></name><name name-style="western"><surname>Leon</surname><given-names>E.P.</given-names></name><name name-style="western"><surname>Viana</surname><given-names>V.S.T.</given-names></name><name name-style="western"><surname>Pasoto</surname><given-names>S.G.</given-names></name></person-group><article-title>Metabolic syndrome in Sj&#246;gren&#8217;s syndrome patients: A relevant concern for clinical monitoring</article-title><source>Clin. Rheumatol.</source><year>2016</year><volume>35</volume><fpage>639</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1007/s10067-015-3072-1</pub-id><pub-id pub-id-type="pmid">26370103</pub-id></element-citation></ref><ref id="B73-nutrients-17-02743"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Servioli</surname><given-names>L.</given-names></name><name name-style="western"><surname>Maciel</surname><given-names>G.</given-names></name><name name-style="western"><surname>Nannini</surname><given-names>C.</given-names></name><name name-style="western"><surname>Crowson</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Matteson</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Cornec</surname><given-names>D.</given-names></name><name name-style="western"><surname>Berti</surname><given-names>A.</given-names></name></person-group><article-title>Association of smoking and obesity on the risk of developing primary Sj&#246;gren syndrome: A population-based cohort study</article-title><source>J. Rheumatol.</source><year>2019</year><volume>46</volume><fpage>727</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.3899/jrheum.180481</pub-id><pub-id pub-id-type="pmid">30647188</pub-id><pub-id pub-id-type="pmcid">PMC6606330</pub-id></element-citation></ref><ref id="B74-nutrients-17-02743"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carubbi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Alunno</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mai</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mercuri</surname><given-names>A.</given-names></name><name name-style="western"><surname>Centorame</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cipollone</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mariani</surname><given-names>F.M.</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bartoloni</surname><given-names>E.</given-names></name><name name-style="western"><surname>Grassi</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Adherence to the Mediterranean diet and the impact on clinical features in primary Sj&#246;gren&#8217;s syndrome</article-title><source>Clin. Exp. Rheumatol.</source><year>2021</year><volume>39</volume><issue>(Suppl. 133)</issue><fpage>190</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.55563/clinexprheumatol/5p5x5p</pub-id><pub-id pub-id-type="pmid">34874828</pub-id></element-citation></ref><ref id="B75-nutrients-17-02743"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>Y.-L.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>Z.-M.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y.-Z.</given-names></name></person-group><article-title>Effects of dietary intervention on human diseases: Molecular mechanisms and therapeutic potential</article-title><source>Signal Transduct. Target. Ther.</source><year>2024</year><volume>9</volume><fpage>59</fpage><pub-id pub-id-type="doi">10.1038/s41392-024-01771-x</pub-id><pub-id pub-id-type="pmid">38462638</pub-id><pub-id pub-id-type="pmcid">PMC10925609</pub-id></element-citation></ref><ref id="B76-nutrients-17-02743"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alwarith</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kahleova</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rembert</surname><given-names>E.</given-names></name><name name-style="western"><surname>Yonas</surname><given-names>W.</given-names></name><name name-style="western"><surname>Dort</surname><given-names>S.</given-names></name><name name-style="western"><surname>Calcagno</surname><given-names>M.</given-names></name><name name-style="western"><surname>Burgess</surname><given-names>N.</given-names></name><name name-style="western"><surname>Crosby</surname><given-names>L.</given-names></name><name name-style="western"><surname>Barnard</surname><given-names>N.D.</given-names></name></person-group><article-title>Nutrition interventions in rheumatoid arthritis: The potential use of plant-based diets. A review</article-title><source>Front. Nutr.</source><year>2019</year><volume>6</volume><elocation-id>141</elocation-id><pub-id pub-id-type="doi">10.3389/fnut.2019.00141</pub-id><pub-id pub-id-type="pmid">31552259</pub-id><pub-id pub-id-type="pmcid">PMC6746966</pub-id></element-citation></ref><ref id="B77-nutrients-17-02743"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knippenberg</surname><given-names>A.</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Wincup</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ciurtin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jury</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Kalea</surname><given-names>A.Z.</given-names></name></person-group><article-title>Plant-based dietary changes may improve symptoms in patients with systemic lupus erythematosus</article-title><source>Lupus</source><year>2022</year><volume>31</volume><fpage>65</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1177/09612033211063795</pub-id><pub-id pub-id-type="pmid">34978516</pub-id><pub-id pub-id-type="pmcid">PMC8793314</pub-id></element-citation></ref><ref id="B78-nutrients-17-02743"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaaya</surname><given-names>C.</given-names></name><name name-style="western"><surname>Raad</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kahale</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chelala</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ziade</surname><given-names>N.</given-names></name><name name-style="western"><surname>Maalouly</surname><given-names>G.</given-names></name></person-group><article-title>Adherence to Mediterranean diet and ocular dryness severity in Sj&#246;gren&#8217;s syndrome: A cross-sectional study</article-title><source>Med. Sci.</source><year>2025</year><volume>13</volume><elocation-id>64</elocation-id><pub-id pub-id-type="doi">10.3390/medsci13020064</pub-id><pub-id pub-id-type="pmcid">PMC12195104</pub-id><pub-id pub-id-type="pmid">40559222</pub-id></element-citation></ref><ref id="B79-nutrients-17-02743"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pringle</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Verstappen</surname><given-names>G.M.P.J.</given-names></name><name name-style="western"><surname>Terpstra</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>He</surname><given-names>A.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>V.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Baird</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Spijkervet</surname><given-names>F.K.L.</given-names></name><etal/></person-group><article-title>Salivary gland stem cells age prematurely in primary Sj&#246;gren&#8217;s syndrome</article-title><source>Arthritis Rheumatol.</source><year>2019</year><volume>71</volume><fpage>133</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1002/art.40659</pub-id><pub-id pub-id-type="pmid">29984480</pub-id><pub-id pub-id-type="pmcid">PMC6607019</pub-id></element-citation></ref><ref id="B80-nutrients-17-02743"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R.-N.</given-names></name><name name-style="western"><surname>Ou</surname><given-names>T.-T.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>C.-H.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y.-Z.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>T.-J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Tseng</surname><given-names>C.-C.</given-names></name><name name-style="western"><surname>Sung</surname><given-names>W.-Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.-C.</given-names></name><name name-style="western"><surname>Yen</surname><given-names>J.-H.</given-names></name></person-group><article-title>NLRP3 gene polymorphisms in rheumatoid arthritis and primary Sjogren&#8217;s syndrome patients</article-title><source>Diagnostics</source><year>2023</year><volume>13</volume><elocation-id>206</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics13020206</pub-id><pub-id pub-id-type="pmid">36673016</pub-id><pub-id pub-id-type="pmcid">PMC9858598</pub-id></element-citation></ref><ref id="B81-nutrients-17-02743"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S.</given-names></name></person-group><article-title>Grp78 regulates NLRP3 inflammasome and participates in Sjogren&#8217;s syndrome</article-title><source>Int. Immunopharmacol.</source><year>2024</year><volume>140</volume><fpage>112815</fpage><pub-id pub-id-type="doi">10.1016/j.intimp.2024.112815</pub-id><pub-id pub-id-type="pmid">39088921</pub-id></element-citation></ref><ref id="B82-nutrients-17-02743"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duregon</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pomatto-Watson</surname><given-names>L.C.D.</given-names></name><name name-style="western"><surname>Bernier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Price</surname><given-names>N.L.</given-names></name><name name-style="western"><surname>de Cabo</surname><given-names>R.</given-names></name></person-group><article-title>Intermittent fasting: From calories to time restriction</article-title><source>Geroscience</source><year>2021</year><volume>43</volume><fpage>1083</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.1007/s11357-021-00335-z</pub-id><pub-id pub-id-type="pmid">33686571</pub-id><pub-id pub-id-type="pmcid">PMC8190218</pub-id></element-citation></ref><ref id="B83-nutrients-17-02743"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nagai</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hase</surname><given-names>K.</given-names></name></person-group><article-title>Dietary intervention impacts immune cell functions and dynamics by inducing metabolic rewiring</article-title><source>Front. Immunol.</source><year>2021</year><volume>11</volume><elocation-id>623989</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.623989</pub-id><pub-id pub-id-type="pmid">33613560</pub-id><pub-id pub-id-type="pmcid">PMC7890027</pub-id></element-citation></ref><ref id="B84-nutrients-17-02743"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Procaccini</surname><given-names>C.</given-names></name><name name-style="western"><surname>de Candia</surname><given-names>P.</given-names></name><name name-style="western"><surname>Russo</surname><given-names>C.</given-names></name><name name-style="western"><surname>De Rosa</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lepore</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Colamatteo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Matarese</surname><given-names>G.</given-names></name></person-group><article-title>Caloric restriction for the immunometabolic control of human health</article-title><source>Cardiovasc. Res.</source><year>2024</year><volume>119</volume><fpage>787</fpage><lpage>2800</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvad035</pub-id><pub-id pub-id-type="pmid">36848376</pub-id></element-citation></ref><ref id="B85-nutrients-17-02743"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Humphreys-Beher</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Brayer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yamachika</surname><given-names>S.</given-names></name><name name-style="western"><surname>Peck</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Jonsson</surname><given-names>R.</given-names></name></person-group><article-title>An alternative perspective to the immune response in autoimmune exocrinopathy: Induction of functional quiescence rather than destructive autoaggression</article-title><source>Scand. J. Immunol.</source><year>1999</year><volume>49</volume><fpage>7</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1046/j.1365-3083.1999.00490.x</pub-id><pub-id pub-id-type="pmid">10023850</pub-id></element-citation></ref><ref id="B86-nutrients-17-02743"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>H.D.</given-names></name><name name-style="western"><surname>Schneyer</surname><given-names>C.A.</given-names></name></person-group><article-title>Salivary gland atrophy in rat induced by liquid diet</article-title><source>Proc. Soc. Exp. Biol. Med.</source><year>1964</year><volume>117</volume><fpage>789</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.3181/00379727-117-29699</pub-id><pub-id pub-id-type="pmid">14244956</pub-id></element-citation></ref><ref id="B87-nutrients-17-02743"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nezu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tanimura</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nakamichi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>T.</given-names></name></person-group><article-title>Responses of salivary glands to intake of soft diet</article-title><source>J. Oral Biosci.</source><year>2022</year><volume>64</volume><fpage>210</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/j.job.2022.03.006</pub-id><pub-id pub-id-type="pmid">35381373</pub-id></element-citation></ref><ref id="B88-nutrients-17-02743"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shiboski</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Shiboski</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Seror</surname><given-names>R.</given-names></name><name name-style="western"><surname>Criswell</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Labetoulle</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lietman</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Rasmussen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scofield</surname><given-names>H.</given-names></name><name name-style="western"><surname>Vitali</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bowman</surname><given-names>S.J.</given-names></name><etal/></person-group><article-title>2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for primary Sj&#246;gren&#8217;s syndrome: A consensus and data-driven methodology involving three international patient cohorts</article-title><source>Arthritis Rheumatol.</source><year>2017</year><volume>69</volume><fpage>35</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1002/art.39859</pub-id><pub-id pub-id-type="pmid">27785888</pub-id><pub-id pub-id-type="pmcid">PMC5650478</pub-id></element-citation></ref><ref id="B89-nutrients-17-02743"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Sheth</surname><given-names>M.</given-names></name><name name-style="western"><surname>Deshpande</surname><given-names>A.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>J.</given-names></name></person-group><article-title>Association between oral microbiome dysbiosis and Sjogren Syndrome. A systematic review of clinical studies</article-title><source>Arch. Oral Biol.</source><year>2025</year><volume>172</volume><elocation-id>106167</elocation-id><pub-id pub-id-type="doi">10.1016/j.archoralbio.2024.106167</pub-id><pub-id pub-id-type="pmid">39798503</pub-id></element-citation></ref><ref id="B90-nutrients-17-02743"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bellando-Randone</surname><given-names>S.</given-names></name><name name-style="western"><surname>Russo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Venerito</surname><given-names>V.</given-names></name><name name-style="western"><surname>Matucci-Cerinic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Iannone</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tangaro</surname><given-names>S.</given-names></name><name name-style="western"><surname>Amedei</surname><given-names>A.</given-names></name></person-group><article-title>Exploring the Oral Microbiome in Rheumatic Diseases, State of Art and Future Prospective in Personalized Medicine with an AI Approach</article-title><source>J. Pers. Med.</source><year>2021</year><volume>11</volume><elocation-id>625</elocation-id><pub-id pub-id-type="doi">10.3390/jpm11070625</pub-id><pub-id pub-id-type="pmid">34209167</pub-id><pub-id pub-id-type="pmcid">PMC8306274</pub-id></element-citation></ref><ref id="B91-nutrients-17-02743"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alam</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>D.I.</given-names></name><name name-style="western"><surname>Park</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.-H.</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>S.</given-names></name><name name-style="western"><surname>Baek</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Park</surname><given-names>S.-H.</given-names></name><etal/></person-group><article-title>Dysbiotic oral microbiota and infected salivary glands in Sj&#246;gren&#8217;s syndrome</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><elocation-id>e0230667</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0230667</pub-id><pub-id pub-id-type="pmid">32208441</pub-id><pub-id pub-id-type="pmcid">PMC7092996</pub-id></element-citation></ref><ref id="B92-nutrients-17-02743"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tseng</surname><given-names>Y.-C.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>K.-S.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>W.-T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>C.-B.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>J.-W.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>C.-P.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.-M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.-P.</given-names></name><name name-style="western"><surname>Chien</surname><given-names>H.-C.</given-names></name><etal/></person-group><article-title>A human oral commensal-mediated protection against Sj&#246;gren&#8217;s syndrome with maintenance of T cell immune homeostasis and improved oral microbiota</article-title><source>NPJ Biofilms Microbiomes</source><year>2025</year><volume>11</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1038/s41522-025-00654-5</pub-id><pub-id pub-id-type="pmid">39820778</pub-id><pub-id pub-id-type="pmcid">PMC11739518</pub-id></element-citation></ref><ref id="B93-nutrients-17-02743"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Yap</surname><given-names>Y.-A.</given-names></name><name name-style="western"><surname>McLeod</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Mari&#241;o</surname><given-names>E.</given-names></name></person-group><article-title>Dietary metabolites and the gut microbiota: An alternative approach to control inflammatory and autoimmune diseases</article-title><source>Clin. Transl. Immunol.</source><year>2016</year><volume>5</volume><fpage>e82</fpage><pub-id pub-id-type="doi">10.1038/cti.2016.29</pub-id><pub-id pub-id-type="pmid">27350881</pub-id><pub-id pub-id-type="pmcid">PMC4910123</pub-id></element-citation></ref><ref id="B94-nutrients-17-02743"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osailan</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Pramanik</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shirlaw</surname><given-names>P.</given-names></name><name name-style="western"><surname>Proctor</surname><given-names>G.B.</given-names></name><name name-style="western"><surname>Challacombe</surname><given-names>S.J.</given-names></name></person-group><article-title>Clinical assessment of oral dryness: Development of a scoring system related to salivary flow and mucosal wetness</article-title><source>Oral Surg. Oral Med. Oral Pathol. Oral Radiol.</source><year>2012</year><volume>114</volume><fpage>97</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1016/j.oooo.2012.05.009</pub-id><pub-id pub-id-type="pmid">22959491</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="nutrients-17-02743-f001" orientation="portrait"><label>Figure 1</label><caption><p>PRISMA Flowchart depicting article selection process.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02743-g001.jpg"/></fig><fig position="float" id="nutrients-17-02743-f002" orientation="portrait"><label>Figure 2</label><caption><p>(<bold>A</bold>) Schematic representation of dietary interventions in mice and their effects on salivation and tear flow. High-fat diets were associated with worsened salivation, whereas caloric restriction, gluten-free diets, and plant-derived supplements (e.g., <italic toggle="yes">Lycium barbarum</italic> polysaccharide [LBP], resveratrol, and triptolide) improved both salivation and tear flow. (<bold>B</bold>) Summary of nutritional interventions in humans with Sj&#246;gren disease, focusing on dry mouth and dry eyes. Liquid diets significantly enhanced both salivary and tear production. The effects of vitamins and minerals were variable, with only one study reporting improvements in both salivation and tear flow. Gluten-free and specialized diets improved tear flow but showed no impact on dry mouth. Herbal and specialized supplements demonstrated promising effects on salivary flow but yielded inconsistent results for tear production.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02743-g002.jpg"/></fig><table-wrap position="float" id="nutrients-17-02743-t001" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02743-t001_Table 1</object-id><label>Table 1</label><caption><p>Summary of animal studies retrieved in the systematic review.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Animal Model</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sex</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disease Features</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nutritional Intervention</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Intervention Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Stimulated Salivary Flow Rate</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Histological Analysis</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Schirmer Test</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Swanson et al., 1989 [<xref rid="B26-nutrients-17-02743" ref-type="bibr">26</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 cases and 24 controls</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Weaned NZB &#215; NZW mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3- to 4-week-old</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The NZB/W mice also developed autoimmune-related exocrine gland disease, resembling the abnormalities observed in SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diets: <break/>(a) 20 animals: HSF (7.7% coconut oil, 1&#8211;3% corn oil);<break/>(b) 20 animals: HUF (9% corn oil); <break/>(c) 20 animals: LF (1.2% corn oil); <break/>Control group: 24 animals fed a conventional rodent diet.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 months</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Destructive infiltration of exocrine glands: <break/>HSF: 47%; <break/>HUF: 41%; <break/>LF: 23%; <break/>Control group: 25%.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSF: 2.2 mm (0.73) <break/>HUF: 2.2 mm (0.97) <break/>LF 3.3 mm (0.78) <break/>Control group: 3.0 mm (1.6)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chandrasekar et al., 1995 [<xref rid="B27-nutrients-17-02743" ref-type="bibr">27</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(NZB &#215; NZW) F1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-week-old</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mice developed age-associated sialoadenitis, characterized by the infiltration of inflammatory mononuclear cells in the salivary glands, resembling human SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mice were fed a semi-purified diet containing either 5% fat AL or 40% CR. The diet composition included the following ingredients: casein (20%), corn oil (5%), starch (32%), dextrose (33%), fiber (4.5%), DL-methionine (0.3%), choline chloride (0.2%), salt mixture (3.5%), and a vitamin mix (vitamin diet fortification) (1.5%). To compensate for decreased food intake, the CR diet was supplemented with twice the amount of the vitamin and mineral mixture. CR mice were initially fed 5&#8211;10% less than the AL group for the first two weeks, 10&#8211;20% less during the third and fourth weeks, and 40% less thereafter.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.5 (young) to 8.5 (old) months</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Young animals:<break/>AL and CR&#8212;presented normal salivary-gland tissues.<break/>Older animals: <break/>CR&#8212;patchy foci of mild chronic peri-acinar and periductal inflammation of 0.247 &#177; 0.120 (<italic toggle="yes">n</italic> = 12) and percentage area of inflammation 0.130 &#177; 0.067%; AL&#8212;dense confluent infiltrates of lymphocytes, with average focus score of 0.824 &#177; 0.152 and percentage area of inflammation 2.410 &#177; 0.793% (<italic toggle="yes">n</italic> = 12; <italic toggle="yes">p</italic> &lt; 0.005, comparing AL and CR mice).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inoue et al., 2016 [<xref rid="B28-nutrients-17-02743" ref-type="bibr">28</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Japan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD/shi mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6-week-old</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD mice, in which loss of lacrimal and salivary-gland function occurred</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The mice were orally administered the vehicle (Milli-Q) or resveratrol (Sigma-Aldrich, St. Louis, MO, USA) at doses of 100 or 250 mg/kg using gastric intubation 6 days per week from 6 to 20 weeks of age (<italic toggle="yes">n</italic> = 6 mice/group). Resveratrol was dissolved in 0.2 mL of H<sub>2</sub>O for administration.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The salivary flow rate was not altered by the resveratrol between 6 weeks and 20 weeks of age, whereas 250 mg/kg resveratrol showed protective effects on the hyposalivation observed in the NOD mice at age 22 weeks.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In the parotid and sublingual salivary glands, no lymphocyte infiltration was observed in any of the groups of NOD mice. The periductal inflammatory cell foci in submandibular glands were not affected by resveratrol administration.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guo et al., 2021 [<xref rid="B29-nutrients-17-02743" ref-type="bibr">29</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8-week-old</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The authors used NOD mice, as an animal model of SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The NOD mice were administered triptolide by means of gastric gavage. The dosage selection for TP [10 &#181;g/(kg/day), 20 &#181;g/(kg/day), and 40 &#181;g/(kg/day)] was determined based on a previous study. Forty-eight NOD mice were divided into 4 groups: Control group (vehicle) (<italic toggle="yes">n</italic> = 12), NOD mice treated with 10 &#181;g/(kg/day) TP (<italic toggle="yes">n</italic> = 12), NOD mice treated with 20 &#181;g/(kg/day) TP (<italic toggle="yes">n</italic> = 12), and NOD mice treated with 40 mg/(kg/day) TP (<italic toggle="yes">n</italic> = 12)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The salivary flow rate of the control group decreased over time. With the increase in TP concentration, the difference between the TP group and the control group was larger.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Focus Score: <break/>Control = 3.1 &#177; 0.21;<break/>Triptolide 10 = 2.4 &#177; 0.18; Triptolide 20 = 1.8 &#177; 0.17; Triptolide 40 = 1.5 &#177; 0.19.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haupt-Jorgensen et al., 2022 [<xref rid="B30-nutrients-17-02743" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Denmark</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD/BomTac mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3- to 13-week-old</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD mice are a widely used model for T1D (type 1 diabetes and SD)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breeding pairs of prediabetic NOD mice were fed a gluten-free modified Altromin diet (the GF diet was prepared by replacing the gluten-containing ingredients with meat protein) or a standard non-purified Altromin diet (STD).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Focus score: GF (score 0.7) and STD (score 3.8) diets (<italic toggle="yes">p</italic> = 0.124). Submandibular glands from GF versus STD mice: 47% (<italic toggle="yes">p</italic> = 0.042) fewer CD68+ cells and 49% (<italic toggle="yes">p</italic> = 0.037) fewer CD4+ cells. In the same organ, there were tendencies (<italic toggle="yes">p</italic> = 0.130&#8211;0.650) to demonstrating fewer CD20+ cells, more CD8+ cells and fewer VEGFR1+ and VEGFR2+ cells (NS).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wang et al., 2021 [<xref rid="B31-nutrients-17-02743" ref-type="bibr">31</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7-week-old</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A NOD mouse model was used, as it spontaneously develops features resembling human SD, such as lymphocytic infiltration in the salivary glands, hyposalivation, and autoantibodies</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Use of <italic toggle="yes">Lycium barbarum</italic> polysaccharide (LBP) by oral administration.<break/>Mice were randomized into four groups (eight per group): <break/>Low-dose LBP (LBP.L) (5 mg kg<sup>&#8722;1</sup> d<sup>&#8722;1</sup>),<break/>High-dose LBP (LBP.H) (10 mg kg<sup>&#8722;1</sup> d<sup>&#8722;1</sup>), <break/>Low-dose recombinant human IL-2 (LDIL-2, 25,000 IU/d), <break/>and Control (saline water).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD mice treated with LBP had increased salivary flow rates compared with the control group.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LBP.L group (histology score: 1.88 &#177; 0.83, foci number: 0.92 &#177; 0.59).<break/><break/>Control group (histology score: 3.38 &#177; 1.06, <italic toggle="yes">p</italic> = 0.014; foci number: 1.87 &#177; 0.92, <italic toggle="yes">p</italic> = 0.045; <italic toggle="yes">n</italic> = 8).<break/><break/>LBP.H group (histology score: 2.38 &#177; 0.92, <italic toggle="yes">p</italic> = 0.206; foci number: 1.13 &#177; 0.53, <italic toggle="yes">p</italic> = 0.193).<break/><break/>LDIL-2 treated group (histology score: 1.50 &#177; 0.76, <italic toggle="yes">p</italic> = 0.002; foci number: 0.50 &#177; 0.54, <italic toggle="yes">p</italic> = 0.002).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Li et al., 2022 [<xref rid="B32-nutrients-17-02743" ref-type="bibr">32</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10-week-old</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD mice, a well-defined mouse model that recapitulates human SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The mice were deprived of food every other day from 10 to 13 weeks of age (ADF). All mice had unrestricted access to water throughout the entire experiment. <break/>Control: standard chow AL diet.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mice in the ADF group exhibited higher salivary flow rate compared to the control group, suggesting the improvement of the salivary secretory function (<italic toggle="yes">p</italic> &lt; 0.05).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H/E staining of submandibular gland sections showed significantly lower leukocyte focus numbers and infiltration areas in the mice with ADF than in the control mice (<italic toggle="yes">p</italic> &lt; 0.05).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zhang et al., 2022 [<xref rid="B20-nutrients-17-02743" ref-type="bibr">20</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WT and IL-14&#945; transgenic mice (IL-14&#945; TG)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The authors used IL-14&#945; transgenic mice (IL-14&#945; TG), a mouse model that mimics the clinical features of SD in the same time frame as in humans. This mouse model not only shows lacrimal gland and salivary-gland inflammation but also shows systemic manifestations of the disease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mice were fed a standard diet (SD, 10 kcal% fat, 1022) and a HFD (60 kcal% fat).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 months</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The levels of salivary-gland secretions of the IL14 HFD mice were significantly lower than the levels of salivary-gland secretions in the WT group and the IL14 group.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The results showed that the IL14 HFD group developed the same submandibular gland (SMG) injuries as the WT HFD group. However, the IL14 HFD group showed more extensive and severe lymphocytic inflammatory infiltration of SMG.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tear production was significantly decreased in both the WT HFD and the IL14 HFD groups, compared with comparable SD groups</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Li et al., 2024 [<xref rid="B33-nutrients-17-02743" ref-type="bibr">33</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Japan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10-week-old</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD mice with newly established SD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mice were fed every other day (ADF) and age- and sex-matched mice were fed a standard chow AL diet (controls).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The authors conducted immunohistochemical analysis:
<list list-type="order"><list-item><p>p16<sup>INK4a</sup> expression in SMG were significantly reduced by ADF (<italic toggle="yes">p</italic> &lt; 0.01);</p></list-item><list-item><p>Expression levels of anti-apoptotic molecules BCL-2, BCL-XL, and MCL-1 in SMG were decreased by ADF;</p></list-item><list-item><p>ADF decreased NLRP3 inflammasome expression level and, consequently, its products (IL-1&#946; and IL-18).</p></list-item></list></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td></tr></tbody></table><table-wrap-foot><fn><p>Note: ADF, alternate day fasting; AL, ad libitum; CR, calorie restriction; GF, gluten-free; HFD, high-fat diet; HSF, high in saturated fat; HUF, high in unsaturated fat; LF, low in fat; LBP, <italic toggle="yes">Lycium barbarum</italic> polysaccharide; NI, no information; NOD, non-obese diabetic; NS, not significant; NZB, New Zealand Black; NZW, New Zealand White; SD, Sj&#246;gren disease; STD, standard diet; TP, triptolide; USA, United States of America; WT, wild type.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="nutrients-17-02743-t002" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02743-t002_Table 2</object-id><label>Table 2</label><caption><p>Summary of human studies retrieved in the systematic review.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author and Year of Publication</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sex</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sj&#246;gren Disease Criteria</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Additional Disease Information</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nutrition Intervention</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Intervention Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">UWSFR</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Stimulated Salivary Flow Rate</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Schirmer Test</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Perceived Improvement in Dryness</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Raffle, 1950 [<xref rid="B34-nutrients-17-02743" ref-type="bibr">34</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UK</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Symptoms: vague rheumatic pains, weakness, lack of appetite and energy, pronounced facial swelling at the parotid regions, swelling under the chin, dry mouth, dysphagia, soreness of the tongue.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">First, vitamin A, 150,000 units daily. Then, vitamin A stopped, and ferrous sulfate 18 g daily started. Then, &#8220;Beplex&#8221; capsules, six per day, were given (6 mg of thiamin hydrochloride, 4.8 mg. of riboflavin, and 60 mg. of nicotinic acid).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No improvement on the buccal condition, but the patient subjectively felt better.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maclaurin et al., 1972 [<xref rid="B35-nutrients-17-02743" ref-type="bibr">35</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">New Zealand</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dryness and soreness of the eyes and mouth for one year. Schirmer&#8217;s test confirmed diminished tear secretion.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GF diet and treatment with vitamin B12 by injection, folic acid, calcium, and other vitamins.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 months</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improvement in tear secretion by Schirmer&#8217;s test</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dry mouth did not improve, improvement in general well-being.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Horrobin and Campbell, 1980 [<xref rid="B36-nutrients-17-02743" ref-type="bibr">36</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Canada</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 F<break/>4 NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52<break/>4 NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">One patient with a history of classic moderate rheumatoid arthritis and history of dry mouth and dry eyes, and the four others with long-established SD.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intake of high-dose (7.5 g/day) vitamin C for a year, with 50 mg/day pyridoxine and 6 &#215; 0.6 mL Evening Primrose Oil capsules per day.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 months</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All five patients had substantial improvements in tear and saliva production.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">McKendry, 1982 [<xref rid="B37-nutrients-17-02743" ref-type="bibr">37</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Canada</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients presenting with subjective oral and ocular dryness.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vitamin C 3.0 g daily and Evening Primrose Oil 6 &#215; 500 mgs. capsules daily for six weeks. Pyridoxine 100 mgs. daily was added to the regimen from week 6 to week 10. At week 10, the Evening Primrose Oil. and Pyridoxine were discontinued and the dose of Vitamin C was tapered to zero over four weeks.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">One patient: subjective and objective evidence of improved oral and ocular lubrication. One patient: subjective improvement without improvement in Schirmer&#8217;s test. One patient: improvement in Schirmer&#8217;s test without subjective improvement. The others had no improvement</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pedersen et al., 1999 [<xref rid="B38-nutrients-17-02743" ref-type="bibr">38</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Denmark</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39 F <break/>1 M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 (range 30&#8211;85)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The diagnosis was based on the criteria proposed by Vitali et al. (1993) [<xref rid="B39-nutrients-17-02743" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Three tablets of Longo Vital at breakfast. <break/>Group A: LV for the first 4 months; <break/>Group B: LV for the last 4 months.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 months <break/>(LV: 4 months/placebo: 4 months)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group A&#8212;Significant increase in 4 months of LV (<italic toggle="yes">p</italic> &lt; 0.001)/Group B&#8212;no significant changes in either period</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group A&#8212;stimulated salivary flow did not change on LV but increased on the subsequent 4 months of placebo (<italic toggle="yes">p</italic> &lt; 0.05)/Group B&#8212;stimulated salivary flow increased only on LV (<italic toggle="yes">p</italic> &lt; 0.05)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant changes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peen et al., 2008 [<xref rid="B40-nutrients-17-02743" ref-type="bibr">40</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Denmark</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients: 23; Controls: 23 (matched age and sex)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 F <break/>2 M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.6 (range 34&#8211;73)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients fulfilling the criteria for SD proposed by the American&#8211;European Consensus Group 2002 [<xref rid="B41-nutrients-17-02743" ref-type="bibr">41</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liquid diet avoiding mastication. The patients were also offered a free fluid dietary supplement in 200 mL boxes containing 1.5 kcal/mL, including 5.6 g protein, 18.8 g carbohydrates, and 5.8 g fat per 100 mL (Fresubin Energy, Fresenius Kabi, Bad Homburg, Germany), to a maximum of 600 mL/day. Controls: not on diet.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients: <break/>week 1: 1.18 (0.73&#8211;2.03); week 4: 1.70 (0.95&#8211;2.69) <break/><italic toggle="yes">p</italic> value: 0.02/Controls: week 1: 0.47 (0.25&#8211;0.84); week 4: 0.47 (0.02&#8211;1.05) <break/><italic toggle="yes">p</italic> value: NS.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients: <break/>week 1: 3.3 (0.39&#8211;4.95); week 4: 7.05 (2.39&#8211;6.55) <break/><italic toggle="yes">p</italic> value: 0.05/Controls: week 1: 16.10 (6.64&#8211;26.31); week 4: 9.71 (4.11&#8211;12.41) <italic toggle="yes">p</italic> value: NS.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salivary flow increased significantly in the 23 patients on the liquid diet for 4 weeks.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Singh et al., 2010 [<xref rid="B42-nutrients-17-02743" ref-type="bibr">42</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">61</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57 F <break/>4 M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">61 (mean age)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biopsy: NI/Focus score: NI/Anti-SSA (Ro): NI/Salivary flow: zero/Schirmer&#8217;s test: NI/Xerostomia: all patients had subjective complaints of dry mouth/Xeropthalmia: NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All patients were on muscarinic agonists for at least 3 months.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo (wheat germ oil): 23 subjects. <break/>TheraTears nutrition (<italic toggle="yes">n</italic>-3 supplement): 38 subjects. (TheraTears nutrition contains 1000 mg of flaxseed oil, 450 mg of EPA, 300 mg of DHA, 163 mg of vitamin E as d-alpha tocopherol, and 20 mg of mixed tocopherol concentrate.) One capsule per day, taken with breakfast.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 months</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic>-3 group: UWSFR increased significantly (SD), 0.076 (0.09) mL/min at baseline to 0.140 (0.18) mL/min at 3 months <break/><italic toggle="yes">p</italic> = 0.029.<break/><break/>Wheat germ oil: the mean (SD) UWSFR increased slightly from 0.065 (0.08) mL/min at baseline to 0.094 (0.11) mL/min at 3 months <break/><italic toggle="yes">p</italic> = 0.135.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic>-3 group: 0.776 (0.74) mL/min at baseline to 1.018 (1.08) mL/min at 3 months <break/><italic toggle="yes">p</italic> = 0.026. <break/><break/>Wheat germ oil: the mean (SD) US increased slightly from 0.919 (0.69) at baseline to 1.02 (0.76) mL/min at 3 months <break/><italic toggle="yes">p</italic> = 0.316.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant changes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Perceived improvement in dry mouth was evaluated with VAS, and it was significant in both groups.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liao et al., 2013 [<xref rid="B43-nutrients-17-02743" ref-type="bibr">43</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Taiwan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biopsy: NI/Focus score: NI/Anti-SSA (Ro): positive/Salivary flow: NI/Schirmer&#8217;s test: NI/Xerostomia: positive/Xeropthalmia: positive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-La SSB: positive/antinuclear antibodies: positive (1:2560), delayed saliva excretion on salivary scintigraphy. Other symptoms: profound hypokalemia, abnormal renal function with hyperphosphaturia, and hypocalcemia.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The patient was placed on potassium citrate (45 mEq/day) and active vitamin D3 (0.25 &#956;g/d) therapy to treat the hypokalemia and vitamin D deficiency, respectively.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The patient experienced no further sicca symptoms or paralysis during outpatient department follow-up treatment.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Goldner et al., 2024 [<xref rid="B44-nutrients-17-02743" ref-type="bibr">44</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40, 54, and 45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patient 1: photosensitivity, fatigue, pain in the legs, dry skin, dry eye, dry mouth, stomach cramping, diarrhea, pelvic pain. <break/><break/>Patient 2: photosensitivity; butterfly rash; constant fatigue; joint stiffness in the fingers, elbows, and knees; severe dry mouth and dry eye; eye inflammation; neuropathy. <break/><break/>Patient 3: Flu-like symptoms, migraines, intermittent dizziness, weakness, dry mouth, recurrent nerve pain in skin, fatigue, light sensitivity, eye pain, trigeminal neuralgia.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Initial RRP&#8212;Include: raw vegetables (unlimited); focus on high intake of leafy greens and cruciferous vegetables, fruits, whole and ground flax and chia seeds, cold-pressed flaxseed oil, water, and vitamin B12 and D supplementation. <break/>Eliminate: all animal products, added oils, processed foods, added sugars, cooked foods, grains, and legumes. <break/><break/>Maintenance phase&#8212;Include: vegetables <break/>(recommended 75% raw), fruits (no recommended restrictions), seeds and nuts, whole and ground flax and chia seeds, water, intact and whole grains, legumes, and vitamin B12 and D supplementation. Eliminate: all animal products, added oils, processed foods, added sugars, and alcohol.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Initial RRP: 4 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dry mouth and eyes resolved immediately (&#8804;1 month) after start of RRP in all 3 patients. Other symptoms also resolved with the continuation of the diet. </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Al-Rawi et al., 2024 [<xref rid="B45-nutrients-17-02743" ref-type="bibr">45</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iraq</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">104</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99 F <break/>5 M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group 1: 53.4 &#177; 12.4; <break/>Group 2: 52.6 &#177; 11.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Based on the 2016 diagnostic criteria from ACR/EULAR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group 1 was given omega-3 dietary supplements. <break/>Group 2: placebo <break/>(two capsules daily).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 months</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UWSFR at baseline (mean): <break/>Group 1: 0.99 mL/min; <break/>Group 2: 1.0 mL/min <break/>(<italic toggle="yes">p</italic> = 0.989). <break/><break/>UWSFR at the last visit (mean): <break/>Group 1: 2.07 mL/min; <break/>Group 2: 1.55 mL/min <break/>(<italic toggle="yes">p</italic> = 0.053).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group 1: <break/>Baseline (mean): 2.38 mm; <break/>Last visit (mean): 6.63 mm <break/>(<italic toggle="yes">p</italic> &lt; 0.001). <break/><break/>Group 2: <break/>Baseline (mean): 2.68 mm; <break/>Last visit (mean): 5.58 mm <break/>(<italic toggle="yes">p</italic> = 0.01).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improvements in eye symptoms including itching, mucous discharge, and photophobia.<break/><break/>Improvement was noted in the xerostomia inventory.</td></tr></tbody></table><table-wrap-foot><fn><p>Note: ACR, American College of Rheumatology; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; EULAR, European League Against Rheumatism; F, female; GF, gluten-free; LV, Longo Vital; M, male; NI, no information; NS, not significant; RRP, rapid recovery/reversal phase; SD, Sj&#246;gren Disease; USA, United States of America; UK, United Kingdom; UWSFR, unstimulated whole salivary flow rate; VAS, visual analog scale.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>